<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">J Exp Med</journal-id><journal-id journal-id-type="iso-abbrev">J Exp Med</journal-id><journal-id journal-id-type="publisher-id">jem</journal-id><journal-title-group><journal-title>The Journal of Experimental Medicine</journal-title></journal-title-group><issn pub-type="ppub">0022-1007</issn><issn pub-type="epub">1540-9538</issn><publisher><publisher-name>Rockefeller University Press</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">39141127</article-id><article-id pub-id-type="pmc">PMC11323366</article-id>
<article-id pub-id-type="publisher-id">jem.20240391</article-id><article-id pub-id-type="doi">10.1084/jem.20240391</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group><subj-group subj-group-type="category"><subject>Infectious Disease and Host Defense</subject><subject>Virology</subject></subj-group></article-categories><title-group><article-title>Transcription of HIV-1 at sites of intact latent provirus integration</article-title><alt-title alt-title-type="short">Transcription of HIV-1 at sites of proviral integration</alt-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-1906-0102</contrib-id><name><surname>Teixeira</surname><given-names>Ana Rafaela</given-names></name><role vocab="credit" vocab-identifier="http://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="http://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role vocab="credit" vocab-identifier="http://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="http://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="http://credit.niso.org/" vocab-term="Visualization" vocab-term-identifier="http://credit.niso.org/contributor-roles/visualization/">Visualization</role><role vocab="credit" vocab-identifier="http://credit.niso.org/" vocab-term="Writing - original draft" vocab-term-identifier="http://credit.niso.org/contributor-roles/writing-original-draft/">Writing - original draft</role><role vocab="credit" vocab-identifier="http://credit.niso.org/" vocab-term="Writing - review &#x00026; editing" vocab-term-identifier="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing - review &#x00026; editing</role><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-2048-4589</contrib-id><name><surname>Bittar</surname><given-names>Cintia</given-names></name><role vocab="credit" vocab-identifier="http://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="http://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role vocab="credit" vocab-identifier="http://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="http://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="http://credit.niso.org/" vocab-term="Visualization" vocab-term-identifier="http://credit.niso.org/contributor-roles/visualization/">Visualization</role><role vocab="credit" vocab-identifier="http://credit.niso.org/" vocab-term="Writing - review &#x00026; editing" vocab-term-identifier="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing - review &#x00026; editing</role><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-7482-7380</contrib-id><name><surname>Silva Santos</surname><given-names>Gabriela S.</given-names></name><role vocab="credit" vocab-identifier="http://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role vocab="credit" vocab-identifier="http://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role vocab="credit" vocab-identifier="http://credit.niso.org/" vocab-term="Software" vocab-term-identifier="http://credit.niso.org/contributor-roles/software/">Software</role><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-2654-0879</contrib-id><name><surname>Oliveira</surname><given-names>Thiago Y.</given-names></name><role vocab="credit" vocab-identifier="http://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role vocab="credit" vocab-identifier="http://credit.niso.org/" vocab-term="Software" vocab-term-identifier="http://credit.niso.org/contributor-roles/software/">Software</role><role vocab="credit" vocab-identifier="http://credit.niso.org/" vocab-term="Visualization" vocab-term-identifier="http://credit.niso.org/contributor-roles/visualization/">Visualization</role><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-5303-2191</contrib-id><name><surname>Huang</surname><given-names>Amy S.</given-names></name><role vocab="credit" vocab-identifier="http://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="http://credit.niso.org/contributor-roles/methodology/">Methodology</role><xref rid="aff2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-5035-6716</contrib-id><name><surname>Linden</surname><given-names>Noemi</given-names></name><role vocab="credit" vocab-identifier="http://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="http://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="http://credit.niso.org/contributor-roles/investigation/">Investigation</role><xref rid="aff3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-5232-4670</contrib-id><name><surname>Ferreira</surname><given-names>Isabella A.T.M.</given-names></name><role vocab="credit" vocab-identifier="http://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="http://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="http://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="http://credit.niso.org/" vocab-term="Validation" vocab-term-identifier="http://credit.niso.org/contributor-roles/validation/">Validation</role><xref rid="aff3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-1800-1784</contrib-id><name><surname>Murdza</surname><given-names>Tetyana</given-names></name><role vocab="credit" vocab-identifier="http://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="http://credit.niso.org/contributor-roles/investigation/">Investigation</role><xref rid="aff4" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-0132-5101</contrib-id><name><surname>Muecksch</surname><given-names>Frauke</given-names></name><role vocab="credit" vocab-identifier="http://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role vocab="credit" vocab-identifier="http://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="http://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="http://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="http://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="http://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="http://credit.niso.org/contributor-roles/supervision/">Supervision</role><xref rid="aff4" ref-type="aff">4</xref><xref rid="aff5" ref-type="aff">5</xref></contrib><contrib contrib-type="author"><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-4470-1231</contrib-id><name><surname>Jones</surname><given-names>R. Brad</given-names></name><role vocab="credit" vocab-identifier="http://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="http://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="http://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role><role vocab="credit" vocab-identifier="http://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="http://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="http://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="http://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="http://credit.niso.org/" vocab-term="Resources" vocab-term-identifier="http://credit.niso.org/contributor-roles/resources/">Resources</role><role vocab="credit" vocab-identifier="http://credit.niso.org/" vocab-term="Writing - review &#x00026; editing" vocab-term-identifier="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing - review &#x00026; editing</role><xref rid="aff3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-1727-8693</contrib-id><name><surname>Caskey</surname><given-names>Marina</given-names></name><role vocab="credit" vocab-identifier="http://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="http://credit.niso.org/" vocab-term="Resources" vocab-term-identifier="http://credit.niso.org/contributor-roles/resources/">Resources</role><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author" corresp="yes" equal-contrib="yes"><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-9696-5234</contrib-id><name><surname>Jankovic</surname><given-names>Mila</given-names></name><role vocab="credit" vocab-identifier="http://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="http://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role vocab="credit" vocab-identifier="http://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="http://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="http://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="http://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="http://credit.niso.org/" vocab-term="Project administration" vocab-term-identifier="http://credit.niso.org/contributor-roles/project-administration/">Project administration</role><role vocab="credit" vocab-identifier="http://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="http://credit.niso.org/contributor-roles/supervision/">Supervision</role><role vocab="credit" vocab-identifier="http://credit.niso.org/" vocab-term="Writing - original draft" vocab-term-identifier="http://credit.niso.org/contributor-roles/writing-original-draft/">Writing - original draft</role><role vocab="credit" vocab-identifier="http://credit.niso.org/" vocab-term="Writing - review &#x00026; editing" vocab-term-identifier="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing - review &#x00026; editing</role><xref rid="aff1" ref-type="aff">1</xref><xref rid="afn1" ref-type="author-notes">*</xref><xref rid="cor2" ref-type="corresp"/></contrib><contrib contrib-type="author" corresp="yes" equal-contrib="yes"><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-0592-8564</contrib-id><name><surname>Nussenzweig</surname><given-names>Michel C.</given-names></name><role vocab="credit" vocab-identifier="http://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="http://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role vocab="credit" vocab-identifier="http://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role vocab="credit" vocab-identifier="http://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="http://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role><role vocab="credit" vocab-identifier="http://credit.niso.org/" vocab-term="Project administration" vocab-term-identifier="http://credit.niso.org/contributor-roles/project-administration/">Project administration</role><role vocab="credit" vocab-identifier="http://credit.niso.org/" vocab-term="Resources" vocab-term-identifier="http://credit.niso.org/contributor-roles/resources/">Resources</role><role vocab="credit" vocab-identifier="http://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="http://credit.niso.org/contributor-roles/supervision/">Supervision</role><role vocab="credit" vocab-identifier="http://credit.niso.org/" vocab-term="Writing - original draft" vocab-term-identifier="http://credit.niso.org/contributor-roles/writing-original-draft/">Writing - original draft</role><role vocab="credit" vocab-identifier="http://credit.niso.org/" vocab-term="Writing - review &#x00026; editing" vocab-term-identifier="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing - review &#x00026; editing</role><xref rid="aff1" ref-type="aff">1</xref><xref rid="aff6" ref-type="aff">6</xref><xref rid="afn1" ref-type="author-notes">*</xref><xref rid="cor1" ref-type="corresp"/></contrib></contrib-group><aff id="aff1">
<label>1</label>Laboratory of Molecular Immunology, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/0420db125</institution-id><institution>The Rockefeller University</institution></institution-wrap>, New York, NY, <country country="us">USA</country></aff><aff id="aff2">
<label>2</label>
<institution-wrap><institution>Tessera Therapeutics</institution></institution-wrap>, Somerville, MA, <country country="us">USA</country></aff><aff id="aff3">
<label>3</label>Division of Infectious Diseases, Department of Medicine, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/02r109517</institution-id><institution>Weill Cornell Medicine</institution></institution-wrap>, New York, NY, <country country="us">USA</country></aff><aff id="aff4">
<label>4</label>Department of Infectious Diseases, Medical Faculty Heidelberg, Virology, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/038t36y30</institution-id><institution>Center for Integrative Infectious Disease Research (CIID), Heidelberg University</institution></institution-wrap>, Heidelberg, <country country="de">Germany</country></aff><aff id="aff5">
<label>5</label>Department of Infectious Diseases, Virology, <institution-wrap><institution>Chica and Heinz Schaller (CHS) Research Group, University Hospital Heidelberg</institution></institution-wrap>, Heidelberg, <country country="de">Germany</country></aff><aff id="aff6">
<label>6</label>
<institution-wrap><institution-id institution-id-type="ror">https://ror.org/006w34k90</institution-id><institution>Howard Hughes Medical Institute</institution></institution-wrap>, Chevy Chase, MD, <country country="us">USA</country></aff><author-notes><corresp id="cor1">Correspondence to Michel C. Nussenzweig: <email>nussen@rockefeller.edu</email></corresp><corresp id="cor2">Mila Jankovic: <email>jakovm@rockefeller.edu</email></corresp><fn fn-type="equal" id="afn1"><label>*</label><p>M. Jankovic and M.C. Nussenzweig contributed equally to this paper.</p></fn><fn fn-type="COI-statement"><p>Disclosures: R.B. Jones reports personal fees from ViiV Healthcare outside the submitted work. M.C Nussenzweig reports personal fees from Gilead and personal fees from Frontier Biosciences outside the submitted work; in addition, M.C. Nussenzweig has a patent to 3BNC117 issued (Gilead) and a patent to 10-1074 issued (Gilead). No other disclosures were reported.</p></fn></author-notes><pub-date iso-8601-date="2024-09-02" pub-type="collection"><day>02</day><month>9</month><year>2024</year></pub-date><pub-date pub-type="epub" iso-8601-date="2024-08-14"><day>14</day><month>8</month><year>2024</year></pub-date><pub-date pub-type="pmc-release"><day>14</day><month>8</month><year>2024</year></pub-date><!--PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>.--><volume>221</volume><issue>9</issue><elocation-id>e20240391</elocation-id><history><date date-type="received" iso-8601-date="2024-03-01"><day>01</day><month>3</month><year>2024</year></date><date date-type="rev-recd" iso-8601-date="2024-05-21"><day>21</day><month>5</month><year>2024</year></date><date date-type="accepted" iso-8601-date="2024-07-30"><day>30</day><month>7</month><year>2024</year></date></history><permissions><copyright-statement>&#x000a9; 2024 Teixeira et al.</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>Teixeira et al.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is available under a Creative Commons License (Attribution 4.0 International, as described at <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><self-uri xlink:href="jem_20240391.pdf"/><abstract abstract-type="teaser"><p>This study uses reporter cells engineered with a minimal expression construct and cells cultured directly from the reservoir of HIV-1 infected individuals to show that proviral transcription in latently infected cells is predominantly dependent on the site of proviral integration.</p></abstract><abstract><p>HIV-1 antiretroviral therapy is highly effective but fails to eliminate a reservoir of latent proviruses, leading to a requirement for life-long treatment. How the site of integration of authentic intact latent proviruses might impact their own or neighboring gene expression or reservoir dynamics is poorly understood. Here, we report on proviral and neighboring gene transcription at sites of intact latent HIV-1 integration in cultured T cells obtained directly from people living with HIV, as well as engineered primary T cells and cell lines. Proviral gene expression was correlated to the level of endogenous gene expression under resting but not activated conditions. Notably, latent proviral promoters were 100&#x02013;10,000&#x000d7; less active than in productively infected cells and had little or no measurable impact on neighboring gene expression under resting or activated conditions. Thus, the site of integration has a dominant effect on the transcriptional activity of intact HIV-1 proviruses in the latent reservoir, thereby influencing cytopathic effects and proviral immune evasion.</p></abstract><funding-group specific-use="FundRef"><award-group><funding-source>
<institution-wrap><institution>National Institutes of Health</institution><institution-id institution-id-type="DOI">http://dx.doi.org/10.13039/100000002</institution-id></institution-wrap>
</funding-source><award-id>UM1 AI100663</award-id><award-id>R01AI129795</award-id></award-group></funding-group><funding-group specific-use="FundRef"><award-group><funding-source>
<institution-wrap><institution>REACH Delaney</institution></institution-wrap>
</funding-source><award-id>UM1 AI164565</award-id></award-group></funding-group><funding-group specific-use="FundRef"><award-group><funding-source>
<institution-wrap><institution>Einstein-Rockefeller-CUNY Center for AIDS Research</institution><institution-id institution-id-type="DOI">http://dx.doi.org/10.13039/100019546</institution-id></institution-wrap>
</funding-source><award-id>1P30AI124414-01A1</award-id></award-group></funding-group><funding-group specific-use="FundRef"><award-group><funding-source>
<institution-wrap><institution>BEAT-HIV Delaney</institution></institution-wrap>
</funding-source><award-id>UM1 AI126620</award-id></award-group></funding-group><funding-group specific-use="FundRef"><award-group><funding-source>
<institution-wrap><institution>Bill and Melinda Gates Foundation</institution><institution-id institution-id-type="DOI">http://dx.doi.org/10.13039/100000865</institution-id></institution-wrap>
</funding-source><award-id>INV-002705</award-id></award-group></funding-group><funding-group specific-use="FundRef"><award-group><funding-source>
<institution-wrap><institution>Stavros Niarchos Foundation</institution><institution-id institution-id-type="DOI">http://dx.doi.org/10.13039/501100004343</institution-id></institution-wrap>
</funding-source></award-group></funding-group><funding-group specific-use="FundRef"><award-group><funding-source>
<institution-wrap><institution>Rockefeller University</institution><institution-id institution-id-type="DOI">http://dx.doi.org/10.13039/100012007</institution-id></institution-wrap>
</funding-source></award-group></funding-group></article-meta></front><body><sec sec-type="introduction" id="s1"><title>Introduction</title><p>HIV-1 proviral integration into the genome of CD4<sup>+</sup> T cells typically leads to the production of up to 10<sup>4</sup> virions per cell and results in cell death by apoptosis (<xref rid="bib68" ref-type="bibr">Wei et al., 1995</xref>; <xref rid="bib54" ref-type="bibr">Perelson et al., 1996</xref>). However, in a small number of instances, the integrated provirus remains latent but can be reactivated in vitro or in vivo upon treatment interruption (<xref rid="bib51" ref-type="bibr">Pace et al., 2011</xref>; <xref rid="bib11" ref-type="bibr">Cohn et al., 2020</xref>; <xref rid="bib42" ref-type="bibr">Liu et al., 2020</xref>; <xref rid="bib21" ref-type="bibr">Dufour et al., 2021</xref>; <xref rid="bib63" ref-type="bibr">Siliciano and Siliciano, 2022</xref>). Antiretroviral therapy (ART) prevents the spread of productive infection and disease progression but does not eliminate a reservoir of infected cells that carry intact latent proviruses (<xref rid="bib70" ref-type="bibr">Wong et al., 1997</xref>; <xref rid="bib10" ref-type="bibr">Chun et al., 1998</xref>; <xref rid="bib24" ref-type="bibr">Finzi et al., 1999</xref>). This reservoir represents the primary barrier to HIV-1 cure (<xref rid="bib40" ref-type="bibr">Li et al., 2016</xref>; <xref rid="bib46" ref-type="bibr">Margolis and Archin, 2017</xref>).</p><p>Obtaining a detailed understanding of the reservoir has been challenging because the cells that carry intact latent proviruses are rare and there are no definitive cell surface markers that can be used to isolate them (<xref rid="bib29" ref-type="bibr">Ho et al., 2013</xref>; <xref rid="bib17" ref-type="bibr">Crooks et al., 2015</xref>; <xref rid="bib3" ref-type="bibr">Bachmann et al., 2019</xref>; <xref rid="bib18" ref-type="bibr">Darcis et al., 2019</xref>; <xref rid="bib11" ref-type="bibr">Cohn et al., 2020</xref>; <xref rid="bib53" ref-type="bibr">Peluso et al., 2020</xref>; <xref rid="bib69" ref-type="bibr">Weymar et al., 2022</xref>; <xref rid="bib67" ref-type="bibr">Sun et al., 2023</xref>; <xref rid="bib71" ref-type="bibr">Wong et al., 2023</xref>). Nevertheless, there has been a great deal of progress in understanding the nature of the reservoir (<xref rid="bib51" ref-type="bibr">Pace et al., 2011</xref>; <xref rid="bib11" ref-type="bibr">Cohn et al., 2020</xref>; <xref rid="bib42" ref-type="bibr">Liu et al., 2020</xref>; <xref rid="bib21" ref-type="bibr">Dufour et al., 2021</xref>; <xref rid="bib63" ref-type="bibr">Siliciano and Siliciano, 2022</xref>). Documented features of the reservoir include the following: (1) CD4<sup>+</sup> T cells that carry intact latent proviruses are oligoclonal (<xref rid="bib43" ref-type="bibr">Lorenzi et al., 2016</xref>; <xref rid="bib64" ref-type="bibr">Simonetti et al., 2016</xref>; <xref rid="bib5" ref-type="bibr">Bui et al., 2017</xref>; <xref rid="bib30" ref-type="bibr">Hosmane et al., 2017</xref>; <xref rid="bib12" ref-type="bibr">Cohn et al., 2018</xref>; <xref rid="bib44" ref-type="bibr">Lu et al., 2018</xref>); (2) the clones of cells carrying intact latent proviruses are dynamic, and while the overall number of T cells carrying latent proviruses decreases over time, they also become more clonal (<xref rid="bib8" ref-type="bibr">Cho et al., 2022</xref>); (3) intact proviruses found in large CD4<sup>+</sup> T cell clones are the least likely to be reactivated (<xref rid="bib43" ref-type="bibr">Lorenzi et al., 2016</xref>); and (4) some intact proviruses in the latent reservoir are transcriptionally active and others are not (<xref rid="bib23" ref-type="bibr">Einkauf et al., 2022</xref>).</p><p>During initial infection, integrase favors proviral deposition in the introns of highly expressed genes associated with regions of accessible chromatin (<xref rid="bib60" ref-type="bibr">Schr&#x000f6;der et al., 2002</xref>; <xref rid="bib27" ref-type="bibr">Han et al., 2004</xref>; <xref rid="bib16" ref-type="bibr">Craigie and Bushman, 2012</xref>). These proviruses are the first to be eliminated due to their cytopathic effects. Over time on ART, and in elite controllers, intact proviruses are enriched in heterochromatin, non-genic regions, and in an opposite orientation to the host gene (<xref rid="bib22" ref-type="bibr">Einkauf et al., 2019</xref>, <xref rid="bib23" ref-type="bibr">2022</xref>; <xref rid="bib33" ref-type="bibr">Jiang et al., 2020</xref>; <xref rid="bib31" ref-type="bibr">Huang et al., 2021</xref>). In addition to centromeric and satellite DNA, integration into zinc finger (ZNF) genes is enriched possibly because these sites are less permissive for provirus expression and subsequent negative selection (<xref rid="bib33" ref-type="bibr">Jiang et al., 2020</xref>; <xref rid="bib31" ref-type="bibr">Huang et al., 2021</xref>). Consistent with this idea, experiments in transformed cell lines using randomly integrated HIV-1 reporter proviruses suggest that transcriptional activity is dependent on the site of integration (<xref rid="bib37" ref-type="bibr">Jordan et al., 2001</xref>; <xref rid="bib39" ref-type="bibr">Lewinski et al., 2005</xref>; <xref rid="bib61" ref-type="bibr">Sherrill-Mix et al., 2013</xref>; <xref rid="bib7" ref-type="bibr">Chen et al., 2017</xref>; <xref rid="bib4" ref-type="bibr">Battivelli et al., 2018</xref>; <xref rid="bib14" ref-type="bibr">Collora and Ho, 2023</xref>). However, the relationship between the site of authentic latent proviral integration and transcriptional activity or its effect on neighboring genes is not known. Understanding how the reservoir of intact latent proviruses is regulated and how it impacts neighboring gene expression in primary CD4<sup>+</sup> T cells is critical to understanding how the reservoir is maintained and how it might be eliminated.</p><p>To address these questions, we analyzed HIV-1 and global gene expression in Jurkat and primary T cells that carry HIV-1 reporters inserted precisely into sites of intact latent provirus integration and in authentic latent CD4<sup>+</sup> T cells isolated directly from people living with HIV (PLWH).</p></sec><sec sec-type="results" id="s2"><title>Results</title><sec id="s3"><title>HIV-1 LTR reporter expression by flow cytometry</title><p>To determine how intact proviruses alter gene expression or are influenced by their position in the host genome, we selected seven well-documented sites of latent HIV-1 integration obtained from PLWH, three of which had been demonstrated to be inducible in vitro (<xref rid="fig1" ref-type="fig">Fig. 1 A</xref>) (<xref rid="bib33" ref-type="bibr">Jiang et al., 2020</xref>; <xref rid="bib31" ref-type="bibr">Huang et al., 2021</xref>; <xref rid="bib23" ref-type="bibr">Einkauf et al., 2022</xref>). The seven sites differed in their documented level of host gene expression, proviral orientation with respect to the neighboring gene, and whether HIV-1 transcripts were detected in primary cells (<xref rid="fig1" ref-type="fig">Fig. 1 A</xref>). Five of the seven sites were found among expanded clones and two in unique CD4<sup>+</sup> T cells (<xref rid="bib33" ref-type="bibr">Jiang et al., 2020</xref>; <xref rid="bib31" ref-type="bibr">Huang et al., 2021</xref>; <xref rid="bib23" ref-type="bibr">Einkauf et al., 2022</xref>). One was in a non-genic region of chr13 and the remainder were in introns of genes expressed at low (<italic toggle="yes">ZNF407</italic>, <italic toggle="yes">ZNF140</italic>), medium (<italic toggle="yes">KDM2A</italic>, <italic toggle="yes">ZNF460</italic>, <italic toggle="yes">KCNA3</italic>), and high (<italic toggle="yes">ATP2B4</italic>) levels (<xref rid="fig1" ref-type="fig">Fig. 1 A</xref>).</p><fig position="float" fig-type="figure" id="fig1"><label>Figure 1.</label><caption><p>
<bold>Selected integration sites and production of reporter T cell clones. (A)</bold> Table of selected integration sites. <bold>(B)</bold> Schematic representation of the methods used to produce reporter T cell lines (see Materials and methods for details). Created with <ext-link xlink:href="https://BioRender.com" ext-link-type="uri">https://BioRender.com</ext-link>.</p></caption><graphic xlink:href="jem_20240391_fig1" position="float"/></fig><p>A reporter construct consisting of an HIV-1 long terminal repeat (LTR), transactivator of transcription (Tat), green fluorescent protein (eGFP), and nano Luciferase (nLuciferase) was inserted into the precise position of each of the seven intact latent proviruses using CRISPR ribonucleoproteins in Jurkat cells or primary CD4<sup>+</sup> T cells. Integration was verified by PCR in expanded clones obtained from single cells (iStrains; <xref rid="fig1" ref-type="fig">Fig. 1 B</xref>). The amplified region encompassed the integration site and construct, and the integrity of both was confirmed by Sanger sequencing. Several independent clones were obtained for <italic toggle="yes">ATP2B4</italic> and <italic toggle="yes">KCNA3</italic> in Jurkat and CD4<sup>+</sup> T cells and for <italic toggle="yes">ZNF407</italic> in Jurkat cells. We were unable to obtain an integration in <italic toggle="yes">ZNF407</italic> in primary CD4<sup>+</sup> T cells. Control cells were transfected and cultured under the same conditions but did not contain a reporter.</p><p>As measured by flow cytometry, reporter expression varied depending on the integration site. There was no detectable expression by reporters integrated into <italic toggle="yes">ZNF140</italic> and <italic toggle="yes">ZNF407,</italic> or a non-genic region in chr13 in Jurkat cells or primary CD4<sup>+</sup> T cells under resting conditions or after activation with phorbol 12-myristate 13-acetate (PMA) and ionomycin or anti-CD3 and -CD28 monoclonal antibodies, respectively (<xref rid="fig2" ref-type="fig">Fig. 2 A</xref> and <xref rid="fig3" ref-type="fig">Fig. 3 A</xref>). The reporters integrated into <italic toggle="yes">ZNF460</italic> and <italic toggle="yes">KDM2A</italic> were also silent in primary CD4<sup>+</sup> T cells, but in contrast to the other three silent genes, they were expressed in a fraction of the cells upon activation (<xref rid="fig3" ref-type="fig">Fig. 3 A</xref>). Reporters integrated into <italic toggle="yes">KCNA3</italic> and <italic toggle="yes">ATP2B4</italic> from multiple independent clones were expressed under resting conditions, and expression was further enhanced by activation, as measured by an increase in the percentage of cells expressing GFP and in their mean fluorescence intensity (<xref rid="fig2" ref-type="fig">Fig. 2 A</xref>, <xref rid="fig3" ref-type="fig">Fig. 3 A</xref>, and <xref rid="figS1" ref-type="fig">Fig. S1, A and B</xref>). To determine whether reporter expression can be enhanced by latency reversal agents (LRAs), we treated Jurkat or primary T cells with LRAs and analyzed them by flow cytometry (<xref rid="figS1" ref-type="fig">Fig. S1, D and E</xref>). Jurkat clones expressing GFP in resting state, iZNF460, iKCNA3, and iATP2B4, treated with romidepsin, panobinostat, and prostratin showed enhanced expression of GFP to levels comparable to activation with PMA/ionomycin (<xref rid="figS1" ref-type="fig">Fig. S1 D</xref>). In contrast, the expression of the reporter integrated into the silent <italic toggle="yes">KDM2A</italic> gene was not altered by the LRAs tested (<xref rid="figS1" ref-type="fig">Fig. S1 D</xref>). In primary T cells carrying integration in <italic toggle="yes">KDM2A</italic>, romidepsin enhanced GFP expression significantly but to a lower level than anti-CD3 and -CD28 antibody&#x02013;mediated activation (<xref rid="figS1" ref-type="fig">Fig. S1 E</xref>). Thus, LRA-induced expression is also integration site dependent.</p><fig position="float" fig-type="figure" id="fig2"><label>Figure 2.</label><caption><p>
<bold>Jurkat reporter lines. (A)</bold> Histograms show GFP fluorescence (x axis) per normalized counts (y axis) for each integration site studied (iStrains, red) and control (blue), in both resting (upper panel) and PMA/ionomycin-activated (lower panel) conditions. <bold>(B)</bold> Graphs show relative LTR (left panel), eGFP (middle panel), and nLuciferase (right panel) expression assessed by qPCR under resting (blue) and PMA/ionomycin-activated (red) conditions. Bars represent the mean relative expression from two independent assays (biological replicates) &#x000b1; SD. <bold>(C)</bold> LTR transcripts per cell (y axis), determined by qPCR, for each integration-positive clone and control, under resting (blue) and activated (red) conditions. CD4<sup>+</sup> T cells infected with HIV-1<sub>Y</sub><sub>U</sub><sub>2</sub> served as positive control (black bar). Bars represent the mean of two independent assays (biological replicates) &#x000b1; SD. <bold>(D)</bold> Relative expression determined by qPCR for host genes neighboring their respective reporter proviruses (iStrains, full bars) and control (striped bars), under resting (left panel, blue), and PMA/ionomycin-activated (right panel, red) conditions. Bars represent the mean relative expression of two independent assays (biological replicates) &#x000b1; SD. Expression of the host gene was averaged across multiple clones to the same reporter integration site. <bold>(E)</bold> Correlation between the relative expression of LTR (y axis) for each Jurkat clone and their respective host gene (x axis), averaged across multiple clones to the same reporter integration site, under resting (left panel, blue) and PMA/ionomycin-activated (right panel, red) conditions. Pearson&#x02019;s correlation coefficients, r, and two-tailed P values were computed for each condition.</p></caption><graphic xlink:href="jem_20240391_fig2" position="float"/></fig><fig position="float" fig-type="figure" id="fig3"><label>Figure 3.</label><caption><p>
<bold>Primary CD4</bold>
<sup>
<bold>+</bold>
</sup>
<bold>T cell reporter lines. (A)</bold> Histograms show GFP fluorescence (x axis) per normalized counts (y axis) for each integration site studied (iStrains, red) and control (blue) in both resting (upper panel) and CD3/CD28-activated (lower panel) conditions. <bold>(B)</bold> Graphs show relative LTR (left panel), eGFP (middle panel), and nLuciferase (right panel) expression assessed by qPCR under resting (blue) and CD3/CD28-activated (red) conditions. Bars represent the mean relative expression from two independent assays (biological replicates) &#x000b1; SD. <bold>(C)</bold> LTR transcripts per cell (y axis), determined by qPCR, for each integration-positive clone and control, under resting (blue) and CD3/CD28-activated (red) conditions. CD4<sup>+</sup> T cells infected with HIV-1<sub>Y</sub><sub>U</sub><sub>2</sub> served as positive control (black bar). Bars represent the mean of two independent assays (biological replicates) &#x000b1; SD. <bold>(D)</bold> Relative expression determined by qPCR for host genes neighboring their respective reporter proviruses (iStrains, full bars) and control (striped bars) under resting (left panel, blue) and CD3/CD28-activated (right panel, red) conditions. Bars represent the mean relative expression of two independent assays (biological replicates) &#x000b1; SD. <bold>(E)</bold> Correlation between the relative expression of LTR (y axis) for each primary T cell clone and their respective host gene (x axis), averaged across multiple clones to the same reporter integration site, under resting (left panel, blue) and activated (right panel, red) conditions. Pearson&#x02019;s correlation coefficients, r, and two-tailed P values were computed for each condition.</p></caption><graphic xlink:href="jem_20240391_fig3" position="float"/></fig><fig position="float" fig-type="supplemental-figure" id="figS1"><label>Figure S1.</label><caption><p>
<bold>GFP expression in reporter cell lines. (A and B)</bold> Percentage of GFP<sup>+</sup> cells as measured by flow cytometry for each integration-positive clone and control, under resting (blue) and PMA/ionomycin- and CD3/CD28-activated (red) conditions, respectively for Jurkat (A) and primary CD4<sup>+</sup> T (B) cells. Bars represent the mean of two independent experiments (biological replicates) &#x000b1; SD. <bold>(C)</bold> Graphs showing relative LTR (left panel), eGFP (middle panel), and nLuciferase (right panel) expression assessed by qPCR in Jurkat cell clones under resting (blue) and CD3/CD28-activated (red) conditions. Bars represent the mean relative expression from two independent assays (biological replicates) &#x000b1; SD. <bold>(D and E)</bold> Representative histograms (left panels) show GFP fluorescence (x axis) per normalized counts (y axis) for Jurkat clones iZNF460, iKDM2A, iKCNA3a, and iATP2B4a (D), and primary CD4<sup>+</sup> T cell clone iKDM2A (E), cultured for 24 h under resting conditions or in the presence of different LRAs or cell activation stimuli (PMA/ionomycin for Jurkat cells, anti-CD3/CD28 monoclonal antibodies for primary cells). Graphs (right panels) show the percentage of GFP<sup>+</sup> cells measured by flow cytometry for the same conditions. Bars represent the mean of two independent experiments (biological replicates) &#x000b1; SD.</p></caption><graphic xlink:href="jem_20240391_figs1" position="float"/></fig></sec><sec id="s4"><title>Proviral RNA expression</title><p>Transcription of intact HIV-1 proviruses in the latent reservoir has been documented by sensitive single-copy PCR assays (<xref rid="bib23" ref-type="bibr">Einkauf et al., 2022</xref>). However, the assay involves multiple rounds of polymerase amplification and is not quantitative. Thus, the amount of transcription at the sites of intact latent proviral integration, how it compares to productive infection, and how it relates to the site of integration have not been examined.</p><p>We performed quantitative PCR (qPCR) assays to determine the level of transcription of integrated proviral reporters under resting and activated conditions in Jurkat and primary CD4<sup>+</sup> T cell lines (<xref rid="fig2" ref-type="fig">Fig. 2 B</xref>, <xref rid="fig3" ref-type="fig">Fig. 3 B</xref>, and <xref rid="figS1" ref-type="fig">Fig. S1 C</xref>). Under resting conditions, reporter LTR expression was either very low at chr13, <italic toggle="yes">ZNF407</italic>, <italic toggle="yes">ZNF140</italic>, <italic toggle="yes">KDM2A</italic>, and <italic toggle="yes">ZNF460</italic> sites in Jurkat cell lines (<xref rid="fig2" ref-type="fig">Fig. 2 B</xref>) or undetectable in primary CD4<sup>+</sup> T cells (<xref rid="fig3" ref-type="fig">Fig. 3 B</xref>). eGFP and nLuciferase were transcribed at lower levels than the LTR and only detectable in reporters integrated at <italic toggle="yes">KCNA3</italic> and <italic toggle="yes">ATP2B4</italic> in primary CD4<sup>+</sup> T cells suggesting incomplete transcript elongation (<xref rid="fig2" ref-type="fig">Fig. 2 B</xref> and <xref rid="fig3" ref-type="fig">Fig. 3 B</xref>). Activation with PMA/ionomycin or anti-CD3/28 antibodies increased LTR mRNA expression to measurable levels at all sites of integration except <italic toggle="yes">ZNF140</italic> in Jurkat cells (<xref rid="fig2" ref-type="fig">Fig. 2 B</xref> and <xref rid="figS1" ref-type="fig">Fig. S1 C</xref>). In contrast, only reporters integrated into <italic toggle="yes">KCNA3</italic> and <italic toggle="yes">ATP2B4</italic> showed increased LTR expression in primary CD4<sup>+</sup> T cells (<xref rid="fig3" ref-type="fig">Fig. 3 B</xref>). However, even after activation, the level of reporter LTR expression, quantified as the number of transcripts per cell, was 10<sup>3</sup>&#x02013;10<sup>4</sup> and 10<sup>2</sup>&#x02013;10<sup>3</sup>-fold lower than HIV-1<sub>YU2</sub> infected CD4<sup>+</sup> T cells in Jurkat and primary CD4<sup>+</sup> T cells, respectively (<xref rid="fig2" ref-type="fig">Fig. 2 C</xref> and <xref rid="fig3" ref-type="fig">Fig. 3 C</xref>). Thus, the results in Jurkat and primary CD4<sup>+</sup> T cells are generally congruent, but reporter expression levels are lower in Jurkat cell lines.</p></sec><sec id="s5"><title>Host gene expression and chromatin architecture</title><p>To determine how proviruses affect nearby host genes, we measured their expression by qPCR under resting and activated conditions. In all cases in Jurkat and primary CD4<sup>+</sup> T cells, host gene mRNA expression was not significantly altered by reporter integration (<xref rid="fig2" ref-type="fig">Fig. 2 D</xref> and <xref rid="fig3" ref-type="fig">Fig. 3 D</xref>). Similar results were obtained using a different reporter that included two LTRs (<xref rid="figS2" ref-type="fig">Fig. S2</xref>). Under resting conditions, reporter LTR expression in Jurkat and primary CD4<sup>+</sup> T cells was directly but not precisely proportional to the level of expression of the host gene (<xref rid="fig2" ref-type="fig">Fig. 2 E</xref> and <xref rid="fig3" ref-type="fig">Fig. 3 E</xref>). For example, in <italic toggle="yes">ZNF140</italic> and <italic toggle="yes">ZNF460</italic>, reporter LTRs are expressed at very low levels in both Jurkat and primary CD4<sup>+</sup> T cells. However, <italic toggle="yes">KDM2A</italic> is expressed at relatively high levels in primary CD4<sup>+</sup> T cells but the reporter is silent (<xref rid="fig3" ref-type="fig">Fig. 3 E</xref>). Notably, there was no significant correlation between the integration site and proviral transcription after activation, suggesting that under these conditions, regulation is no longer dominated by the host gene.</p><fig position="float" fig-type="supplemental-figure" id="figS2"><label>Figure S2.</label><caption><p>
<bold>Expression of host genes carrying reporter proviruses in Jurkat clones.</bold> Relative expression of host genes <italic toggle="yes">PYKFYVE</italic> and <italic toggle="yes">Fiz1</italic> in Jurkat clones (full bars) and control (striped bars), under resting (blue) and activated (red) conditions. Bars represent the mean relative expression &#x000b1; SD for each gene for three technical replicates, for two independent assays (biological replicates, I and II).</p></caption><graphic xlink:href="jem_20240391_figs2" position="float"/></fig><p>To determine how proviral integration might alter genome accessibility in or near the site of integration, we performed an assay for transposase-accessible chromatin with sequencing (ATAC-seq) on all Jurkat and primary CD4<sup>+</sup> T cell lines. The reporter LTR was accessible in all cell lines except in <italic toggle="yes">ZNF140</italic> and, surprisingly, <italic toggle="yes">ZNF460</italic> in Jurkat cells and the non-genic region in chr13 in primary CD4<sup>+</sup> T cells (<xref rid="fig4" ref-type="fig">Fig. 4, A and B</xref>). Thus, even in the absence of measurable transcription, the reporter remained accessible in most sites of latent integration. Notably, except for <italic toggle="yes">KCNA3</italic> in primary CD4<sup>+</sup> T cells, the presence of the reporter did not alter neighboring genome chromatin accessibility irrespective of proviral transcription under resting or activated conditions (<xref rid="fig4" ref-type="fig">Fig. 4 C</xref>; and <xref rid="figS3" ref-type="fig">Figs. S3</xref> and <xref rid="figS4" ref-type="fig">S4</xref>). We conclude that HIV-1 LTR reporter integration at authentic latent sites in Jurkat or primary CD4<sup>+</sup> T cells does not alter local gene expression and only occasionally impacts local chromatin accessibility.</p><fig position="float" fig-type="figure" id="fig4"><label>Figure 4.</label><caption><p>
<bold>Chromatin accessibility. (A and B)</bold> Chromatin accessibility in Jurkat (A) and primary CD4<sup>+</sup> T cell clones (B) as measured by ATAC-seq for the reporter construct at each integration site and control under resting conditions. <bold>(C)</bold> Graph shows ATAC-seq for <italic toggle="yes">ATP2B4</italic> encompassing the reporter integration site in control and clones that carry the reporter in <italic toggle="yes">KDM2A</italic>, <italic toggle="yes">ATP2B4</italic>. Blue shading indicates the site of reporter integration. Graphs were generated by averaging the normalized reads from three technical replicates for each clone.</p></caption><graphic xlink:href="jem_20240391_fig4" position="float"/></fig><fig position="float" fig-type="supplemental-figure" id="figS3"><label>Figure S3.</label><caption><p>
<bold>Chromatin accessibility around reporter construct integration site in Jurkat cell clones. (A&#x02013;G)</bold> Chromatin accessibility measured by ATAC-seq in a 200,000 kb window of the genome around each of the integration sites for all Jurkat clones: chr13 (A), chr18 (<italic toggle="yes">ZNF407</italic>, B), chr12 (<italic toggle="yes">ZNF140</italic>, C), chr11 (<italic toggle="yes">KDM2A</italic>, D), chr19 (<italic toggle="yes">ZNF460</italic>, E), chr1 (<italic toggle="yes">KCNA3</italic>, F), and chr1 (<italic toggle="yes">ATP2B4</italic>, G). Graphs were generated by averaging the normalized reads from three technical replicates for each clone.</p></caption><graphic xlink:href="jem_20240391_figs3" position="float"/></fig><fig position="float" fig-type="supplemental-figure" id="figS4"><label>Figure S4.</label><caption><p>
<bold>Chromatin accessibility around reporter construct integration site in primary CD4</bold>
<sup>
<bold>+</bold>
</sup>
<bold>T cell clones. (A&#x02013;F)</bold> Chromatin accessibility measured by ATAC-seq in a 200,000 kb window of the genome around each of the integration sites for all primary CD4<sup>+</sup> T cell clones: chr13 (A), chr12 (<italic toggle="yes">ZNF140</italic>, B), chr11 (<italic toggle="yes">KDM2A</italic>, C), chr19 (<italic toggle="yes">ZNF460</italic>, D), chr1 (<italic toggle="yes">KCNA3</italic>, E), and chr1 (<italic toggle="yes">ATP2B4</italic>, F). Graphs were generated by averaging the normalized reads from three technical replicates for each clone.</p></caption><graphic xlink:href="jem_20240391_figs4" position="float"/></fig></sec><sec id="s6"><title>Intact latent HIV-1 proviruses</title><p>CD4<sup>+</sup> T cells carrying intact latent HIV-1 proviruses are rare and express no singular cell surface marker that distinguishes them from T cells other than their unique T cell receptor (TCR) (<xref rid="bib12" ref-type="bibr">Cohn et al., 2018</xref>; <xref rid="bib15" ref-type="bibr">Collora et al., 2022</xref>; <xref rid="bib23" ref-type="bibr">Einkauf et al., 2022</xref>; <xref rid="bib69" ref-type="bibr">Weymar et al., 2022</xref>; <xref rid="bib67" ref-type="bibr">Sun et al., 2023</xref>; <xref rid="bib72" ref-type="bibr">Wu et al., 2023</xref>). To examine HIV-1 expression in authentic latent reservoir cells, we enriched CD4<sup>+</sup> T cells carrying replication-competent latent proviruses by means of their specific TCRs (<xref rid="bib69" ref-type="bibr">Weymar et al., 2022</xref>): #603 and #5104 with HIV-1 integrated into <italic toggle="yes">ZNF486</italic> and human satellite 3 (HSat3) DNA in Chr22. The sorted cells were then expanded under limiting dilution conditions in the presence of irradiated feeder cells and antiretroviral drugs (ARVs). The presence and frequencies of the infected clones in the expanded cells lines were verified by PCR assays for their specific TCRs and HIV-1 sequences (<xref rid="fig5" ref-type="fig">Fig. 5 A</xref>). Cell lines were obtained in which at least half of the cells represented the T cell clones of interest with intact proviruses integrated into <italic toggle="yes">ZNF486</italic> and Chr22 HSat3.</p><fig position="float" fig-type="figure" id="fig5"><label>Figure 5.</label><caption><p>
<bold>HIV-infected cells from PLWH. (A)</bold> Schematic representation of the methods used to grow out HIV-1&#x02013;infected cells from ART-suppressed individuals (<xref rid="bib69" ref-type="bibr">Weymar et al., 2022</xref>). Created with <ext-link xlink:href="https://BioRender.com" ext-link-type="uri">https://BioRender.com</ext-link>. <bold>(B and C)</bold> UMAP of 10X single-cell gene expression data showing the position of the cells expressing the latent clones&#x02019; specific TCR (red dots) (B) and the fraction of latent cells in each cluster (C), for participants 603 (upper panels) and 5104 (lower panels) from ex vivo cells (left panels, data from <xref rid="bib69" ref-type="bibr">Weymar et al. [2022]</xref>), and cultured cells under resting (middle panels) and activated (right panels) conditions. <bold>(D)</bold> Histograms show HIV-1 Gag p24 expression in HIV<sup>+</sup> cells (red) and non-infected cells (blue) of cultures derived from 603 to 5104, under resting (upper panel) and activated (lower panel) conditions. <bold>(E)</bold> Relative expression of LTR (purple bars), <italic toggle="yes">gag</italic> (red bars), and <italic toggle="yes">env</italic> (blue bars) by qPCR for 603 and 5104 HIV<sup>+</sup> cells under resting and activated conditions. Bars represent the mean relative expression of two independent assays (biological replicates) &#x000b1; SD. <bold>(F)</bold> LTR transcripts per cell determined by qPCR, in cells from 603 to 5104 and in Jurkat and primary T cells reporter lines with proviruses integrated into <italic toggle="yes">ATP2B4</italic>, under resting (blue) and activated (red) conditions and HIV-1<sub>YU2</sub> controls. Bars represent the mean of two independent experiments (biological replicates) &#x000b1; SD. <bold>(G)</bold> Relative expression determined by 10X Genomics single-cell mRNA sequencing of host gene neighboring HIV-1 proviral integration (<italic toggle="yes">ZNF486</italic>) in HIV-infected (HIV<sup>+</sup>) and non-infected (HIV<sup>&#x02212;</sup>) cells from the same cell population under resting (blue bars) and activated (red bars) conditions. Bars represent the mean of the respective population from one assay &#x000b1; standard deviation representing population variance.</p></caption><graphic xlink:href="jem_20240391_fig5" position="float"/></fig><p>Primary CD4<sup>+</sup> T cells carrying intact latent proviruses isolated directly from individuals 5104 and 603 are enriched in T cell populations with specific transcriptional profiles (<xref rid="bib69" ref-type="bibr">Weymar et al., 2022</xref>). To determine the transcriptional profile of cultured lines of CD4<sup>+</sup> T cells carrying integrated HIV-1 proviruses in <italic toggle="yes">ZNF486</italic> and Chr22 HSat3, we performed single-cell mRNA sequencing experiments using the 10X Genomics platform. Specific TCR expression was used to identify the latent cells and map them onto our previous data set using a cut-off of 95% confidence (<xref rid="fig5" ref-type="fig">Fig. 5, B and C</xref> and Materials and methods) (<xref rid="bib69" ref-type="bibr">Weymar et al., 2022</xref>). Cultured and ex vivo cells containing latent HIV-1 proviruses showed closely related transcriptional profiles (<xref rid="fig5" ref-type="fig">Fig. 5, B and C</xref>).</p><p>The enriched populations of resting (3 wk after activation) and activated (24 h after anti-CD3 and -CD28 monoclonal antibody stimulation) CD4<sup>+</sup> T cells carrying the 5104 and 603 HIV-1 proviruses were initially examined for p24 expression by flow cytometry (<xref rid="fig5" ref-type="fig">Fig. 5 D</xref>). The HIV-1 provirus integrated into Chr22 HSat3 showed expression under both resting and activated conditions (<xref rid="fig5" ref-type="fig">Fig. 5 D</xref>). In contrast, the provirus integrated into <italic toggle="yes">ZNF486</italic>, a gene expressed at only low levels, failed to show detectable p24 expression under resting or activated conditions (<xref rid="fig5" ref-type="fig">Fig. 5 D</xref>).</p><p>HIV-1 LTR, <italic toggle="yes">gag</italic>, and <italic toggle="yes">env</italic> mRNA expression were measured by qPCR corrected for the fraction of infected cells in the culture (<xref rid="fig5" ref-type="fig">Fig. 5 E</xref> and Materials and methods). The HIV-1 provirus integrated into Chr22 HSat3 showed similar levels of expression of LTR, <italic toggle="yes">gag</italic>, and <italic toggle="yes">env</italic> under resting and activated conditions. In addition, we found multiple spliced transcripts associated with productive infection in single-cell transcriptome analysis (<xref rid="figS5" ref-type="fig">Fig. S5</xref>). In contrast, the HIV-1 provirus integrated into <italic toggle="yes">ZNF486</italic> only showed LTR, <italic toggle="yes">gag</italic>, and <italic toggle="yes">env</italic> transcripts after activation (<xref rid="fig5" ref-type="fig">Fig. 5 E</xref>). When compared to productive infection with HIV-1<sub>YU2</sub>, the proviruses in Chr22 HSat3 and <italic toggle="yes">ZNF486</italic> were expressed at &#x0003e;100 and &#x0003e;27,000-fold lower levels, respectively (<xref rid="fig5" ref-type="fig">Fig. 5 F</xref>). When compared with reporter proviruses integrated into <italic toggle="yes">ATP2B4,</italic> the level of LTR expression obtained from cultured CD4<sup>+</sup> T cells carrying latent HIV-1 was 10- and 100-fold higher than in primary CD4<sup>+</sup> T cells and Jurkat cells, respectively. We conclude that authentic latent HIV-1 proviruses integrated at different sites in the genome of CD4<sup>+</sup> T cells show different levels of expression and ability to respond to activation. In addition, proviruses integrated at latent sites are expressed at far lower levels than in productive infection.</p><fig position="float" fig-type="supplemental-figure" id="figS5"><label>Figure S5.</label><caption><p>
<bold>HIV-1 RNA splice variants.</bold> Sashimi plot showing scRNA-seq reads of 10X single-cell gene-expression data mapping to the HIV genome (bottom), in infected cells of participant 5104 under resting conditions. Splice junctions are represented as arcs connecting exons and the histogram represents the read coverage at each junction. The number of reads mapping to each junction is indicated by the numbers associated with each arc.</p></caption><graphic xlink:href="jem_20240391_figs5" position="float"/></fig><p>To determine whether the latent HIV-1 proviruses in the cultured cells altered neighboring host gene transcription (<italic toggle="yes">ZNF486</italic>), their expression was compared with non-infected cells from the same culture in the 10X Genomics data set. We found no significant difference in the expression of the gene neighboring the integrated HIV-1 provirus between infected and non-infected cells irrespective of activation (<xref rid="fig5" ref-type="fig">Fig. 5 G</xref>).</p></sec></sec><sec sec-type="discussion" id="s7"><title>Discussion</title><p>HIV-1 infection typically results in the death of the infected cell. However, CD4<sup>+</sup> T cells harboring intact chromosomally integrated HIV-1 proviruses can persist for years in individuals who are virally suppressed on ART (<xref rid="bib21" ref-type="bibr">Dufour et al., 2021</xref>; <xref rid="bib41" ref-type="bibr">Lichterfeld et al., 2022</xref>; <xref rid="bib63" ref-type="bibr">Siliciano and Siliciano, 2022</xref>). The provirus is silent in some of these latent cells, which may explain why they persist, but intact proviral transcription has been detected using sensitive but non-quantitative PCR methods (<xref rid="bib23" ref-type="bibr">Einkauf et al., 2022</xref>). We have examined HIV-1 proviral transcription at sites of authentic intact latent proviral integration in Jurkat cell lines, primary CD4<sup>+</sup> T cells, and CD4<sup>+</sup> T cell lines derived from PLWH. The data reveal that in resting, but not activated conditions, the transcriptional activity at the site of intact proviral integration is correlated to the level of proviral gene expression. Notably, the intact proviruses studied had little or no detectable impact on neighboring gene expression.</p><p>The reservoir of CD4<sup>+</sup> T cells that harbor latent proviruses is both heterogeneous and dynamic. It is composed of clones of CD4<sup>+</sup> T cells that expand and contract in a manner that is in part dependent on antigenic stimulation and trophic cytokines required for CD4<sup>+</sup> T cell longevity (<xref rid="bib19" ref-type="bibr">Demoustier et al., 2002</xref>; <xref rid="bib20" ref-type="bibr">Douek et al., 2002</xref>; <xref rid="bib9" ref-type="bibr">Chomont et al., 2009</xref>; <xref rid="bib58" ref-type="bibr">Saleh et al., 2011</xref>; <xref rid="bib34" ref-type="bibr">Jones et al., 2012</xref>; <xref rid="bib13" ref-type="bibr">Cohn et al., 2015</xref>; <xref rid="bib43" ref-type="bibr">Lorenzi et al., 2016</xref>; <xref rid="bib5" ref-type="bibr">Bui et al., 2017</xref>; <xref rid="bib30" ref-type="bibr">Hosmane et al., 2017</xref>; <xref rid="bib38" ref-type="bibr">Lee et al., 2017</xref>; <xref rid="bib55" ref-type="bibr">Pinzone et al., 2019</xref>; <xref rid="bib59" ref-type="bibr">De Scheerder et al., 2019</xref>; <xref rid="bib2" ref-type="bibr">Antar et al., 2020</xref>; <xref rid="bib48" ref-type="bibr">Mendoza et al., 2020</xref>; <xref rid="bib65" ref-type="bibr">Simonetti et al., 2021</xref>; <xref rid="bib8" ref-type="bibr">Cho et al., 2022</xref>). Over time, the measurable reservoir contracts with an initial half-life of &#x0223c;4 years and becomes more clonal (<xref rid="bib62" ref-type="bibr">Siliciano et al., 2003</xref>; <xref rid="bib17" ref-type="bibr">Crooks et al., 2015</xref>; <xref rid="bib3" ref-type="bibr">Bachmann et al., 2019</xref>; <xref rid="bib53" ref-type="bibr">Peluso et al., 2020</xref>; <xref rid="bib8" ref-type="bibr">Cho et al., 2022</xref>). Larger clones of CD4<sup>+</sup> T cells harboring intact proviruses appear to be more difficult to reactivate (<xref rid="bib43" ref-type="bibr">Lorenzi et al., 2016</xref>), and their proviruses are preferentially found in transcriptionally inactive parts of the genome (<xref rid="bib22" ref-type="bibr">Einkauf et al., 2019</xref>; <xref rid="bib31" ref-type="bibr">Huang et al., 2021</xref>). Sensitive PCR-based methods indicate that this shift in the reservoir is associated with retroviral transcription with preferential survival of silent clones (<xref rid="bib23" ref-type="bibr">Einkauf et al., 2022</xref>). Thus, the transcriptional status of the intact provirus appears to be an essential element in determining its longevity. Our experiments indicate that there is a great deal of variability in the level of latent proviral expression that tracks with integration site and cell type. How the site of integration of intact latent proviruses or its transcription might alter latent cell longevity is not known, but the mRNA or protein products of the virus could have a direct effect on the cell or indirectly engage host immunity.</p><p>We found little effect on transcription of neighboring genes by reporter proviruses or HIV-1 integrated at nine sites of intact latent proviral integration in Jurkat cell lines, primary CD4<sup>+</sup> T cells, or CD4<sup>+</sup> T cells obtained from PLWH and grown in culture. Initially, intact latent proviruses are preferentially found in introns of genic regions in the opposite transcriptional orientation to the transcriptional start site (<xref rid="bib22" ref-type="bibr">Einkauf et al., 2019</xref>; <xref rid="bib31" ref-type="bibr">Huang et al., 2021</xref>). Over time, in chronically infected individuals under ART and elite controllers, intact latent proviruses accumulate in ZNF genes and non-genic regions (<xref rid="bib22" ref-type="bibr">Einkauf et al., 2019</xref>; <xref rid="bib33" ref-type="bibr">Jiang et al., 2020</xref>; <xref rid="bib31" ref-type="bibr">Huang et al., 2021</xref>). Our collection of integration sites mirrors this selection, and therefore the observation that intact latent proviruses have little measurable effect on the neighboring genome may be biased by the origins of the sample set. Nevertheless, the integrations examined include unique proviruses found only once and others found in expanded clones.</p><p>In contrast to the absence of proviral influence on neighboring genes, the transcriptional status of the proviruses was directly correlated to that of the genes at integration sites. Notably, the correlation between the proximal host gene expression and LTR transcription was lost upon T cell activation. In some instances, proviral transcription was increased even as proximal host gene expression was downregulated. These results are consistent with a baseline Tat-independent phase during which basal expression depends mostly on host factors and a second activation phase in which a Tat-dependent positive feedback loop promotes proviral transcription (<xref rid="bib37" ref-type="bibr">Jordan et al., 2001</xref>). Consistent with this idea, proviruses integrated in highly repressed genomic regions, i.e., <italic toggle="yes">ZNF140</italic> or in non-genic regions, that do not express Tat, remained silent after T cell stimulation. Our findings are consistent with observations made with randomly integrated reporter proviruses in cell lines that the level of HIV expression depends on the DNA integration site (<xref rid="bib37" ref-type="bibr">Jordan et al., 2001</xref>, <xref rid="bib36" ref-type="bibr">2003</xref>; <xref rid="bib39" ref-type="bibr">Lewinski et al., 2005</xref>; <xref rid="bib66" ref-type="bibr">Skupsky et al., 2010</xref>). However, our sample size is limited, and a larger and more diverse group of authentic latent integration sites is necessary to understand the overall influence of integration sites on proviral expression precisely. Moreover, our reporters are missing components of the provirus that can impact the host cell and promote proviral survival and transcription (<xref rid="bib45" ref-type="bibr">Malim and Emerman, 2008</xref>; <xref rid="bib6" ref-type="bibr">Cesana et al., 2017</xref>; <xref rid="bib55" ref-type="bibr">Pinzone et al., 2019</xref>; <xref rid="bib73" ref-type="bibr">Yeh et al., 2020</xref>). Their absence may in part explain why transcription from the indicator lines is lower than the authentic latently infected cell lines carrying an intact provirus in the same genomic location.</p><p>Notably, we found somewhat variable levels of expression between clones carrying the same integration. In addition, only a fraction of CD4<sup>+</sup> T cells expressed the reporters integrated in <italic toggle="yes">KDM2A</italic> and <italic toggle="yes">ZNF460</italic> after activation. Similarly, only a fraction of the latently infected cells obtained from PLWH expressed p24. Our observations are consistent with the finding that HIV-1 transcription is inherently stochastic (<xref rid="bib50" ref-type="bibr">Ne et al., 2018</xref>; <xref rid="bib49" ref-type="bibr">Mori and Valente, 2020</xref>), which may result in varying levels of gene expression in single cells within a clonal population. This effect may be further compounded by the stochasticity of host gene transcription in the clones (<xref rid="bib56" ref-type="bibr">Raj and Oudenaarden, 2008</xref>). This variability may in part explain why activation of proviruses in vitro requires multiple rounds of stimulation (<xref rid="bib30" ref-type="bibr">Hosmane et al., 2017</xref>).</p><p>We studied two cell lines derived directly from latently infected cells obtained from PLWH. Proviral transcription was detected in cells where HIV-1 was integrated in Chr22 HSat3, but not in cells carrying a provirus integrated in <italic toggle="yes">ZNF486</italic>, a gene expressed at low levels. In all cases, the levels of HIV-1 transcription from sites of intact latent integration were at least two orders of magnitude below the levels found in productively infected cells. Although insufficient to kill all the infected cells, the level of proviral transcription from the Chr22 HSat3 integration was sufficient to produce an infectious virus (data not shown). Thus, latent CD4<sup>+</sup> T cells carrying an HIV-1 provirus integrated into Chr22 HSat3 are also likely to produce enough viral protein to be visible to the immune system.</p><p>In conclusion, the direct relationship between integration site and transcriptional regulation provides a road map for understanding how individual proviruses in the reservoir are selected against and how they contribute to viral rebound.</p></sec><sec sec-type="materials|methods" id="s8"><title>Materials and methods</title><sec id="s9"><title>Participant material and cell lines</title><p>Jurkat cells were procured from ATCC (clone E6-1, TIB-152). Primary CD4<sup>+</sup> T cells were isolated from frozen peripheral blood mononuclear cells (PBMCs) of a healthy individual, while latent HIV<sup>+</sup> cells were isolated as described below from frozen PBMCs of participants of a previous study. Study participants were recruited at the Rockefeller University Hospital and gave informed written consent before participation in the study. The study protocols and procedures (Rockefeller University IRB&#x02013;approved Protocols MCA-0866/TSC-0910 and MCA-0965/TSC-0910) met the standards of good clinical practice and were approved by the institutional review board of the Rockefeller University. Participant cohort information is described in <xref rid="sup1" ref-type="supplementary-material">Table S1</xref> and in a previous publication (<xref rid="bib69" ref-type="bibr">Weymar et al., 2022</xref>).</p></sec><sec id="s10"><title>CRISPR RNA (crRNA) design</title><p>crRNAs were designed using the Integrated DNA Technologies crRNA design tool (<ext-link xlink:href="http://www.idtdna.com" ext-link-type="uri">http://www.idtdna.com</ext-link>) and synthesized by Integrated DNA Technologies as Alt-R CRISPR/Cas9 RNAs. crRNA sequences are listed in <xref rid="sup2" ref-type="supplementary-material">Table S2</xref>.</p></sec><sec id="s11"><title>Homology-directed repair template (HDRT) preparation and AAV production</title><p>HDRT sequences (<xref rid="sup1" ref-type="supplementary-material">Table S1</xref>) were cloned into a pAAV vector using the Gibson assembly technique (<xref rid="bib26" ref-type="bibr">Gibson et al., 2009</xref>) with the NEBuilder HiFi DNA Assembly Master Mix (cat. E2621L; New England Biolabs). AAVs carrying each HDRT were produced as previously described (<xref rid="bib28" ref-type="bibr">Hartweger et al., 2023</xref>). Our strategy is optimized for targeting efficiency and would not accommodate a full-length provirus that cannot be incorporated into AAV.</p></sec><sec id="s12"><title>Nucleofection of Jurkat and primary human CD4<sup>+</sup> T cells</title><p>Genome editing was achieved through a previously described combination of CRISPR targeting and AAV-mediated homologous recombination (<xref rid="bib47" ref-type="bibr">Martin et al., 2019</xref>).</p><p>Primary CD4<sup>+</sup> T cells were enriched from healthy donor cryopreserved PBMCs by negative selection (CD4<sup>+</sup> T Cell Isolation Kit human, cat. 130-096-533; Miltenyi Biotec) and activated for 72 h with 10 &#x000b5;g/ml of plate-bound Ultra-LEAF purified anti-human CD3 monoclonal antibody (clone OKT3, cat. 317325; BioLegend) and 5 &#x000b5;g/ml of soluble Ultra-LEAF purified anti-human CD28 monoclonal antibody (clone 28.2, cat. 302933; BioLegend) in R10 medium (RPMI-1640 medium supplemented with 10% heat-inactivated FBS, 10 mM Hepes, antibiotic-antimycotic (1&#x000d7;) and 2 mM <italic toggle="yes">L</italic>-glutamine [all from Gibco]) supplemented with recombinant human IL-2 (50 U/ml; cat. 10799068001; Roche).</p><p>For a 100 &#x000b5;l transfection, 1 &#x000b5;l of 200 &#x000b5;M of gene-specific crRNA and 1 &#x000b5;l 200 &#x000b5;M trans-activating crRNA (tracrRNA) in duplex buffer (all from Integrated DNA Technologies) were combined, denatured at 95&#x000b0;C for 5 min, and renatured for 5 min at room temperature. Then, 5.6 &#x000b5;l PBS and 2.4 &#x000b5;l 61 &#x000b5;M Cas9 (Alt-R <italic toggle="yes">S.p.</italic> Cas9 Nuclease V3, cat. 1081058; Integrated DNA Technologies) were added and the mixture was incubated for 20 min. Finally, 4 &#x000b5;l 100 &#x000b5;M electroporation enhancer in duplex buffer was added to 10 &#x000b5;l of the RNPs and the mixture was incubated for a further 1&#x02013;2 min.</p><p>Nucleofection of Jurkat cells was performed using SE Cell Line 4D-Nucleofector X Kit L (cat. V4XC-1012; Lonza), while the P3 Primary Cell 4D-Nucleofector X Kit L (cat. V4XP-3024; Lonza) was used for primary T CD4<sup>+</sup> T cells, as previously described (<xref rid="bib32" ref-type="bibr">Hultquist et al., 2019</xref>).</p><p>After nucleofection cells were transferred into a 12-well plate containing R10 medium and the corresponding HDRT-carrying AAV.</p></sec><sec id="s13"><title>Jurkat and primary human CD4<sup>+</sup> T cells</title><p>3 days after nucleofection, cells were stained with Fixable Viability Dye eFluor 780 (cat. 65-0865-14; Invitrogen) and single-cell sorted using a FACSymphony S6 using FACSDiva software (version 9.5.1; BD Biosciences) into R10 (Jurkats) or activation medium (R10 + 50 U/ml IL-2, 0.1 &#x000b5;g/ml of anti-CD3 and -CD28 monoclonal antibodies) plus feeder cells (1 &#x000d7; 10<sup>6</sup>/ml NK and CD8<sup>+</sup> T cell&#x02013;depleted, 5,000 rad irradiated allogeneic PBMCs). 3 weeks after sorting, a small fraction of the cells was collected, genomic DNA was extracted (QuickExtract DNA Extraction Solution, cat. QE09050; Lucigen), and the remainder was restimulated with fresh medium and cultured for an additional 14 days (<xref rid="bib35" ref-type="bibr">Jones et al., 2016</xref>).</p><p>Clones were screened for integration with combinations of HDRT- and gene-specific primers, covering the entire construct and the integration sites (<xref rid="sup2" ref-type="supplementary-material">Table S2</xref>). PCRs were performed using Phusion Green Hot Start II High-Fidelity DNA Polymerase (cat. F537S; Thermo Fisher Scientific) and Sanger sequencing of gel extracted amplicons performed (Azenta Life Sciences).</p></sec><sec id="s14"><title>CD4<sup>+</sup> T cells from individuals on ART</title><p>CD4<sup>+</sup> T cells harboring intact latent HIV-1 proviruses were enriched using their TCRs (<xref rid="bib69" ref-type="bibr">Weymar et al., 2022</xref>).</p><p>CD4<sup>+</sup> T cells from participants 603 (Rockefeller University IRB&#x02013;approved Protocols MCA-0866/TSC-0910) and 5104 (Protocols MCA-0965/TSC-0910) were isolated by magnetic separation using CD4<sup>+</sup> T Cell Isolation Kit, human (cat. 130-091-155; Miltenyi Biotec) and CD45RA MicroBeads, human (cat. 130-045-901; Miltenyi Biotec), and prepared for cell sorting exactly as described (<xref rid="bib69" ref-type="bibr">Weymar et al., 2022</xref>). Cells from 603 (CD4<sup>+</sup>TRBC1<sup>+</sup>TRBV19<sup>+</sup>) and 5104 (CD3<sup>+</sup>CD4<sup>+</sup>TRBC1<sup>+</sup>TRBV<sup>&#x02212;</sup>) were sorted into 96 well &#x0201c;U&#x0201d; bottom plates (five cells per well) containing 200 &#x000b5;l of activation media (composition described above), plus feeder cells, supplemented with the following ARVs: 1 &#x000b5;M tenofovir, 1 &#x000b5;M emtricitabine, 1 &#x003bc;M nevirapine, and 10 &#x000b5;M T-20. Cell sorting was performed on FACSymphony S6 using FACSDiva software (version 9.5.1; BD Biosciences) and data were analyzed using FlowJo (version 10.10.0; BD Biosciences). The culture media was replaced twice a week to replenish ARVs and avoid new infections.</p><p>3 weeks after sorting, cells were screened for the presence of the HIV clone of interest by Env PCR and sequencing (<xref rid="bib57" ref-type="bibr">Salazar-Gonzalez et al., 2008</xref>). Cell lines containing clones of interest were expanded in a T25 culture flask in 10 ml of activation medium. The frequency of latent cells in the cultures was determined 3 weeks after expansion by sorting single cells into 10 &#x000b5;l of RLT buffer (cat 79216; Qiagen) using Agencourt RNAClean XP magnetic beads (cat. A63987; Beckman Coulter) for DNA preparation and Env PCR.</p></sec><sec id="s15"><title>Activation of cultured cells</title><p>Jurkat cells were activated in R10 medium supplemented with PMA (25 ng/ml, cat. P1585; Sigma-Aldrich) and ionomycin (1 &#x003bc;g/ml, cat. I9657; Sigma-Aldrich) or R10 supplemented with anti-human CD3 and CD28 antibodies (as above) for 24 h.</p><p>Primary CD4<sup>+</sup> T cells carrying reporter constructs or those obtained from individuals 603 and 5,104 or controls, 3&#x02013;4 weeks after the last stimulation in activation medium plus feeder cells, were stimulated with activation medium (described above) for either 24 h or 1 week. In parallel, cells were maintained in resting conditions by culturing in simple R10 or R10 supplemented with 10 ng/ml of recombinant human interleukin-7 (IL-7, cat. BT-007-010; R&#x00026;D Systems) for 1 wk. For LRA experiments, resting cells were cultured for 24 h in R10 containing (+)-JQ1 (1 &#x000b5;M, cat. SML1524-5MG; Sigma-Aldrich), prostratin (2.5 &#x000b5;M, cat. P0077-1MG; Sigma-Aldrich), SAHA (0.5 &#x000b5;M, cat. SML0061-5MG; Sigma-Aldrich), romidepsin (5 nM, cat. 14083; Active Motif), or panobinostat (50 nM, cat. SML3060-10MG; Sigma-Aldrich).</p></sec><sec id="s16"><title>Flow cytometric analysis</title><p>T cell clones were assessed for GFP expression by flow cytometry. Cells were stained with Fixable Viability Dye eFluor 780 and the following monoclonal antibodies: TexasRed-PE conjugated anti-human CD3 (clone 7D6, cat. MHCD0317; Invitrogen); PerCP/Cyanine5.5 conjugated anti-human CD4 (clone OKT4, cat. 317428; BioLegend); and Brilliant Violet&#x02013;conjugated anti-human CD25 (clone BC56, cat. 302634; BioLegend).</p><p>HIV Gag p24 expression was evaluated by flow cytometry in CD4<sup>+</sup> T cells derived from participants 603 and 5104. Cells were fixed and permeabilized using BD Cytofix/Cytoperm Fixation/Permeabilization Kit (cat. 554714; BD Biosciences) and stained for Gag p24 protein with anti-HIV-1 core antigen monoclonal antibody (clone KC57, cat. 6604665; Beckman Coulter).</p><p>Cells were analyzed in a FACS Symphony A5 flow cytometer running FACS Diva software (version 8.5; BD Biosciences) and data were analyzed using FlowJo (version 10.10.0; BD Biosciences). Only live cells, CD25<sup>high</sup> (activation conditions) or CD25<sup>low</sup> (resting conditions) were considered for measuring GFP or p24 fluorescence.</p></sec><sec id="s17"><title>qPCR</title><p>RNA was purified from the bulk clonal populations using the RNeasy Plus Micro kit (cat. 74034; Qiagen) and converted to cDNA using SuperScript III Reverse Transcriptase (cat. 18080-093; Invitrogen) using a combination of random primers (cat. 48190011; Invitrogen) and LTR-specific primers for reporter primary cells, plus primers to polyA, nef, tat-rev, and pol for HIV<sup>+</sup> cells (<xref rid="sup2" ref-type="supplementary-material">Table S2</xref>) (<xref rid="bib23" ref-type="bibr">Einkauf et al., 2022</xref>).</p><p>qPCR was performed on cDNA using TaqMan Fast Advanced Master Mix for qPCR (cat. 4444558; Applied Biosystems) with 500 nM primers and 250 nM probe plus 1 &#x000b5;l of cDNA. For relative quantification of expression, normalization was performed against the <italic toggle="yes">PPIA</italic> gene. Primers and probes used for quantification of LTR, eGFP, and nanoLuciferase were from Integrated DNA Technologies (<xref rid="sup2" ref-type="supplementary-material">Table S2</xref>). For host gene expression, we used predesigned PrimeTime qPCR Assays (Integrated DNA Technologies): <italic toggle="yes">ZNF407</italic> &#x02013; Hs.PT.58.4027445; <italic toggle="yes">ZNF140</italic> &#x02013; Hs.PT.58.39945645; <italic toggle="yes">KDM2A</italic> &#x02013; Hs.PT.58.815648; <italic toggle="yes">ZNF460</italic> &#x02013; Hs.PT.58.24604991; <italic toggle="yes">KCNA3</italic> &#x02013; Hs.PT.58.2591067.g; <italic toggle="yes">ATP2B4</italic> &#x02013; Hs.PT.56a.26489531.g; <italic toggle="yes">PPIA</italic> &#x02013; Hs.PT.58v.38887593.g; PIKFYVE &#x02013; Hs.PT.58.26959495 and Hs.PT.58.40848161; and FIZ1 &#x02013; Hs.PT.58.2780215 and Hs.PT.58.5062508. HIV-specific primers for poly-A, nef, tat-rev, pol, and long LTR were as previously described (<xref rid="bib52" ref-type="bibr">Palmer et al., 2003</xref>; <xref rid="bib25" ref-type="bibr">Gaebler et al., 2019</xref>; <xref rid="bib23" ref-type="bibr">Einkauf et al., 2022</xref>) and provided in <xref rid="sup2" ref-type="supplementary-material">Table S2</xref>. Relative expression was calculated as <inline-formula><mml:math id="m1" overflow="scroll"><mml:mrow><mml:msup><mml:mn>2</mml:mn><mml:mrow><mml:mo>&#x02212;</mml:mo><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:mi>C</mml:mi><mml:msub><mml:mi>t</mml:mi><mml:mrow><mml:mi>t</mml:mi><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:mo>&#x02212;</mml:mo><mml:mi>C</mml:mi><mml:msub><mml:mi>t</mml:mi><mml:mrow><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>f</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow></mml:mrow></mml:msup></mml:mrow></mml:math></inline-formula>. The number of LTR transcripts were enumerated in a qPCR reaction using the same LTR primers as above. A standard curve of 10-fold serial dilutions of a plasmid carrying a LTR sequence was created by plotting known DNA copy numbers in each dilution to their respective Ct value. Ct values measured for LTR in each sample were input in the standard curve and the transcript copy number thus obtained was divided by the number of cells, or infected cells for HIV<sup>+</sup> cell cultures, equivalent to input volume of cDNA in the reaction to obtain the number of LTR transcripts per cell.</p></sec><sec id="s18"><title>ATAC-seq</title><p>Dead cells were removed from the culture using the Dead Cell Removal Kit (cat. 130-090-101; Miltenyi Biotec). Then, 100,000 Jurkat cells or primary CD4<sup>+</sup> T cells were used per reaction. For primary T cells, each clone was sampled in both resting and activated conditions as described above. Three replicates were performed per condition. Cells were lysed and DNA tagmented, purified, and amplified using an ATAC-seq kit (cat. 53150; Active Motif). The libraries were sequenced using Illumina NextSeq 550 paired-end sequencing.</p><p>The human genome assembly hg38 was modified adding HIV inserts at specified loci using custom scripts. Subsequently, all libraries were mapped to this modified genome using bowtie2 with the parameters --local --very-sensitive-local. Duplicated reads were then removed with Picard MarkDuplicates with default parameters. Regions with enriched signal throughout the genome were obtained using macs2 for peak calling with the parameters --format BAMPE --nomodel &#x02013;nolambda --cutoff-analysis, and genome blacklist regions (<ext-link xlink:href="https://github.com/Boyle-Lab/Blacklist" ext-link-type="uri">https://github.com/Boyle-Lab/Blacklist</ext-link>) were removed (<xref rid="bib1" ref-type="bibr">Amemiya et al., 2019</xref>). Differentially accessible regions were identified using edgeR.</p></sec><sec id="s19"><title>10X Genomics</title><p>10X Genomics gene expression and V(D)J libraries were generated with the Chromium Single Cell 5&#x02032; Library &#x00026; Gel Bead Kit (cat. PN-1000014; 10X Genomics) and Chromium Single Cell V(D)J Enrichment Kit, Human T Cell (cat. PN-1000005; 10X Genomics) as described in the 10X Genomics protocol. The 5&#x02032; expression library and the V(D)J library were sequenced with NovaSeq 6000 S1 (100 cycles) (cat. 20012865; Illumina).</p></sec><sec id="s20"><title>Single-cell RNA-seq (scRNA-seq) and single-cell TCR-seq processing</title><p>scRNA-seq binary base call (BCL) files underwent demultiplexing and were transformed into FASTQ files using BCLtoFastq, followed by alignment against a modified hg38 that includes specific HIV sequences for each subject utilizing CellRanger (v7.2.0). Analysis was performed in R studio using Seurat (v5.0.1). Cells exhibiting mitochondrial content over 10% and/or feature counts outside the 200 to 2,500 range were excluded. Sample batches were merged, then normalized, and scaled using SCTransform. Single-cell TCR-seq FASTQ files were aligned to the standard CellRanger VDJ reference using CellRanger (v7.2.0). The resulting contig annotations were filtered and examined in R studio. Cells harboring TCRs identical to those found by Weymar and colleagues (<xref rid="bib69" ref-type="bibr">Weymar et al., 2022</xref>) were classified as latent cells, whereas those with diverse TCRs were identified as non-infected cells.</p></sec><sec id="s21"><title>Mapping scRNA-seq from cultured cells to previously published uniform manifold approximation and projection (UMAP)</title><p>The UMAP from a previous report (<xref rid="bib69" ref-type="bibr">Weymar et al., 2022</xref>) served as the reference, and the cultured cells from each subject were anchored and mapped using the FindTransferAnchors and MapQuery functions from Seurat (reference.reduction = "pca", dims = 1:30, reduction.model = umap, refdata = clusters). Only cells with a prediction score of 0.95 or higher for label transferring were selected to create <xref rid="fig5" ref-type="fig">Fig. 5 B</xref>.</p></sec><sec id="s22"><title>Statistical analysis</title><p>Pearson&#x02019;s correlation coefficients, r, and two-tailed P values were computed for the relationship between the host gene and reporter LTR expression. Statistical analyses were performed in GraphPad PRISM version 10.</p><p>Analysis of ATAC-seq and single-cell sequencing data were processed and analyzed using R studio version 2023.12.1+402 running R version 3.3.0.</p></sec><sec id="s23"><title>Online supplemental material</title><p>
<xref rid="figS1" ref-type="fig">Fig. S1</xref> shows quantification of flow cytometry data and LRA experimental results. <xref rid="figS2" ref-type="fig">Fig. S2</xref> shows the levels of reporter LTR transcription at two additional integration sites. <xref rid="figS3" ref-type="fig">Figs. S3</xref> and <xref rid="figS4" ref-type="fig">S4</xref> show chromatin accessibility around the reporter construct integration site in Jurkat and primary CD4<sup>+</sup> T cell clones, respectively. <xref rid="figS5" ref-type="fig">Fig. S5</xref> shows HIV-1 RNA splice variants mapped to the genome from 10X Genomics data. <xref rid="sup1" ref-type="supplementary-material">Table S1</xref> details the clinical characteristics of the participants of previous studies whose cells were used in the current work. <xref rid="sup2" ref-type="supplementary-material">Table S2</xref> lists crRNA sequences, annotated HDRT sequences, and primer sequences for the various assays.</p></sec></sec><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material id="sup1" position="float" content-type="local-data"><label>Table S1</label><caption><p>shows the clinical characteristics of the study participants.</p></caption><media xlink:href="jem_20240391_tables1.docx"/></supplementary-material><supplementary-material id="sup2" position="float" content-type="local-data"><label>Table S2</label><caption><p>lists crRNA sequences, annotated HDRT sequences, and primer sequences for the various assays.</p></caption><media xlink:href="jem_20240391_tables2.xls"/></supplementary-material></sec></body><back><ack><title>Acknowledgments</title><p>We thank all study participants who devoted time to our research, the Rockefeller University Hospital Research support office and nursing staff, all members of the Nussenzweig laboratory for discussions, and M. Jankovic, G. Scrivanti, and D. Solari for laboratory support, as well as L. Cohn for discussions and for critically reading the manuscript. We thank C. Zhao, H. Duan, C. Lai, and S. Huang from the Genomics Resource Center at Rockefeller University for preparing and sequencing the 10X Genomics and ATAC-seq libraries. We also thank J.P. Truman and K.M. Gordon for operating the cell sorters.</p><p>This work was supported by the National Institutes of Health (grants UM1 AI100663 and R01AI129795 to M.C. Nussenzweig), REACH Delaney (grant UM1 AI164565 to M. Caskey and R.B. Jones), the Einstein-Rockefeller-CUNY Center for AIDS Research (grant 1P30AI124414-01A1), BEAT-HIV Delaney (grant UM1 AI126620 to M. Caskey), the Bill and Melinda Gates Foundation (Collaboration for AIDS Vaccine discovery grant INV-002705), and the Stavros Niarchos Foundation (SNF) as part of its grant to the SNF Institute for Global Infectious Disease Research at The Rockefeller University. M.C. Nussenzweig is a Howard Hughes Medical Institute (HHMI) Investigator. This article is subject to HHMI&#x02019;s Open Access to Publications policy. HHMI lab heads have previously granted a non-exclusive CC BY 4.0 license to the public and a sublicensable license to HHMI in their research articles. Pursuant to those licenses, the author-accepted manuscript of this article can be made freely available under a CC BY 4.0 license immediately upon publication. Open Access funding provided by Rockefeller University.</p><p>Author contributions: A.R. Teixeira: Conceptualization, Formal analysis, Investigation, Visualization, Writing&#x02014;original draft, Writing&#x02014;review &#x00026; editing, C. Bittar: Conceptualization, Formal analysis, Investigation, Visualization, Writing&#x02014;review &#x00026; editing, G.S. Silva Santos: Data curation, Formal analysis, Software, T.Y. Oliveira: Formal analysis, Software, Visualization, A.S. Huang: Methodology, N.L. Linden: Conceptualization, Investigation, I.A.T.M. Ferreira: Conceptualization, Investigation, Validation, T. Murdza: Investigation, F. Muecksch: Formal analysis, Investigation, Methodology, Supervision, R.B. Jones: Conceptualization, Funding acquisition, Investigation, Methodology, Resources, Writing&#x02014;review &#x00026; editing, M. Caskey: Conceptualization, Resources, M. Jankovic: Conceptualization, Formal analysis, Investigation, Methodology, Project administration, Supervision, Writing&#x02014;original draft, Writing&#x02014;review &#x00026; editing, M.C. Nussenzweig: Conceptualization, Data curation, Formal analysis, Funding acquisition, Project administration, Resources, Supervision, Writing&#x02014;original draft, Writing&#x02014;review &#x00026; editing.</p></ack><sec sec-type="data-availability"><title>Data availability</title><p>10X Genomics (underlying <xref rid="fig5" ref-type="fig">Figs. 5</xref> and <xref rid="figS5" ref-type="fig">S5</xref>) and ATAC-seq data (underlying <xref rid="fig4" ref-type="fig">Figs. 4</xref>, <xref rid="figS3" ref-type="fig">S3</xref>, and <xref rid="figS4" ref-type="fig">S4</xref>) generated in this project are publicly available as of the date of publication and are archived in the National Center for Biotechnology Information (NCBI) Gene Expression Omnibus (GEO) database under accession number <ext-link xlink:href="GSE268010" ext-link-type="NCBI:geo">GSE268010</ext-link>. The data partially used in <xref rid="fig5" ref-type="fig">Fig. 5</xref> are openly available at NCBI GEO accession number <ext-link xlink:href="GSE204756" ext-link-type="NCBI:geo">GSE204756</ext-link>. All codes used in this work are publicly available as of the date of publication. The code for single-cell analysis is available at <ext-link xlink:href="https://doi.org/10.5281/zenodo.6950427" ext-link-type="uri">https://doi.org/10.5281/zenodo.6950427</ext-link>. The code to identify the TCR of the latent clone of interest is publicly available on GitHub (<ext-link xlink:href="https://github.com/victor-ramos/demultiplex_and_assembly_TCR" ext-link-type="uri">https://github.com/victor-ramos/demultiplex_and_assembly_TCR</ext-link>) and Zenodo (<ext-link xlink:href="https://doi.org/10.5281/zenodo.6954076" ext-link-type="uri">https://doi.org/10.5281/zenodo.6954076</ext-link>).</p></sec><ref-list><title>References</title><ref id="bib1"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Amemiya</surname>, <given-names>H.M.</given-names></string-name>, <string-name><given-names>A.</given-names><surname>Kundaje</surname></string-name>, and <string-name><given-names>A.P.</given-names><surname>Boyle</surname></string-name></person-group>. <year>2019</year>. <article-title>The ENCODE blacklist: Identification of problematic regions of the genome</article-title>. <source>Sci. Rep.</source><volume>9</volume>:<fpage>9354</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-019-45839-z</pub-id><pub-id pub-id-type="pmid">31249361</pub-id>
</mixed-citation></ref><ref id="bib2"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Antar</surname>, <given-names>A.A.R.</given-names></string-name>, <string-name><given-names>K.M.</given-names><surname>Jenike</surname></string-name>, <string-name><given-names>S.</given-names><surname>Jang</surname></string-name>, <string-name><given-names>D.N.</given-names><surname>Rigau</surname></string-name>, <string-name><given-names>D.B.</given-names><surname>Reeves</surname></string-name>, <string-name><given-names>R.</given-names><surname>Hoh</surname></string-name>, <string-name><given-names>M.R.</given-names><surname>Krone</surname></string-name>, <string-name><given-names>J.C.</given-names><surname>Keruly</surname></string-name>, <string-name><given-names>R.D.</given-names><surname>Moore</surname></string-name>, <string-name><given-names>J.T.</given-names><surname>Schiffer</surname></string-name>, <etal/></person-group>. <year>2020</year>. <article-title>Longitudinal study reveals HIV-1-infected CD4<sup>+</sup> T cell dynamics during long-term antiretroviral therapy</article-title>. <source>J. Clin. Invest.</source><volume>130</volume>:<fpage>3543</fpage>&#x02013;<lpage>3559</lpage>. <pub-id pub-id-type="doi">10.1172/JCI135953</pub-id><pub-id pub-id-type="pmid">32191639</pub-id>
</mixed-citation></ref><ref id="bib3"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Bachmann</surname>, <given-names>N.</given-names></string-name>, <string-name><given-names>C.</given-names><surname>von Siebenthal</surname></string-name>, <string-name><given-names>V.</given-names><surname>Vongrad</surname></string-name>, <string-name><given-names>T.</given-names><surname>Turk</surname></string-name>, <string-name><given-names>K.</given-names><surname>Neumann</surname></string-name>, <string-name><given-names>N.</given-names><surname>Beerenwinkel</surname></string-name>, <string-name><given-names>J.</given-names><surname>Bogojeska</surname></string-name>, <string-name><given-names>J.</given-names><surname>Fellay</surname></string-name>, <string-name><given-names>V.</given-names><surname>Roth</surname></string-name>, <string-name><given-names>Y.L.</given-names><surname>Kok</surname></string-name>, <etal/></person-group>. <year>2019</year>. <article-title>Determinants of HIV-1 reservoir size and long-term dynamics during suppressive ART</article-title>. <source>Nat. Commun.</source><volume>10</volume>:<fpage>3193</fpage>. <pub-id pub-id-type="doi">10.1038/s41467-019-10884-9</pub-id><pub-id pub-id-type="pmid">31324762</pub-id>
</mixed-citation></ref><ref id="bib4"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Battivelli</surname>, <given-names>E.</given-names></string-name>, <string-name><given-names>M.S.</given-names><surname>Dahabieh</surname></string-name>, <string-name><given-names>M.</given-names><surname>Abdel-Mohsen</surname></string-name>, <string-name><given-names>J.P.</given-names><surname>Svensson</surname></string-name>, <string-name><given-names>I.</given-names><surname>Tojal Da Silva</surname></string-name>, <string-name><given-names>L.B.</given-names><surname>Cohn</surname></string-name>, <string-name><given-names>A.</given-names><surname>Gramatica</surname></string-name>, <string-name><given-names>S.</given-names><surname>Deeks</surname></string-name>, <string-name><given-names>W.C.</given-names><surname>Greene</surname></string-name>, <string-name><given-names>S.K.</given-names><surname>Pillai</surname></string-name>, and <string-name><given-names>E.</given-names><surname>Verdin</surname></string-name></person-group>. <year>2018</year>. <article-title>Distinct chromatin functional states correlate with HIV latency reactivation in infected primary CD4(+) T cells</article-title>. <source>Elife</source>. <volume>7</volume>:<elocation-id>e34655</elocation-id>. <pub-id pub-id-type="doi">10.7554/eLife.34655</pub-id><pub-id pub-id-type="pmid">29714165</pub-id>
</mixed-citation></ref><ref id="bib5"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Bui</surname>, <given-names>J.K.</given-names></string-name>, <string-name><given-names>M.D.</given-names><surname>Sobolewski</surname></string-name>, <string-name><given-names>B.F.</given-names><surname>Keele</surname></string-name>, <string-name><given-names>J.</given-names><surname>Spindler</surname></string-name>, <string-name><given-names>A.</given-names><surname>Musick</surname></string-name>, <string-name><given-names>A.</given-names><surname>Wiegand</surname></string-name>, <string-name><given-names>B.T.</given-names><surname>Luke</surname></string-name>, <string-name><given-names>W.</given-names><surname>Shao</surname></string-name>, <string-name><given-names>S.H.</given-names><surname>Hughes</surname></string-name>, <string-name><given-names>J.M.</given-names><surname>Coffin</surname></string-name>, <etal/></person-group>. <year>2017</year>. <article-title>Proviruses with identical sequences comprise a large fraction of the replication-competent HIV reservoir</article-title>. <source>PLoS Pathog.</source><volume>13</volume>:<elocation-id>e1006283</elocation-id>. <pub-id pub-id-type="doi">10.1371/journal.ppat.1006283</pub-id><pub-id pub-id-type="pmid">28328934</pub-id>
</mixed-citation></ref><ref id="bib6"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Cesana</surname>, <given-names>D.</given-names></string-name>, <string-name><given-names>F.R.</given-names><surname>Santoni de Sio</surname></string-name>, <string-name><given-names>L.</given-names><surname>Rudilosso</surname></string-name>, <string-name><given-names>P.</given-names><surname>Gallina</surname></string-name>, <string-name><given-names>A.</given-names><surname>Calabria</surname></string-name>, <string-name><given-names>S.</given-names><surname>Beretta</surname></string-name>, <string-name><given-names>I.</given-names><surname>Merelli</surname></string-name>, <string-name><given-names>E.</given-names><surname>Bruzzesi</surname></string-name>, <string-name><given-names>L.</given-names><surname>Passerini</surname></string-name>, <string-name><given-names>S.</given-names><surname>Nozza</surname></string-name>, <etal/></person-group>. <year>2017</year>. <article-title>HIV-1-mediated insertional activation of STAT5B and BACH2 trigger viral reservoir in T regulatory cells</article-title>. <source>Nat. Commun.</source><volume>8</volume>:<fpage>498</fpage>. <pub-id pub-id-type="doi">10.1038/s41467-017-00609-1</pub-id><pub-id pub-id-type="pmid">28887441</pub-id>
</mixed-citation></ref><ref id="bib7"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Chen</surname>, <given-names>H.C.</given-names></string-name>, <string-name><given-names>J.P.</given-names><surname>Martinez</surname></string-name>, <string-name><given-names>E.</given-names><surname>Zorita</surname></string-name>, <string-name><given-names>A.</given-names><surname>Meyerhans</surname></string-name>, and <string-name><given-names>G.J.</given-names><surname>Filion</surname></string-name></person-group>. <year>2017</year>. <article-title>Position effects influence HIV latency reversal</article-title>. <source>Nat. Struct. Mol. Biol.</source><volume>24</volume>:<fpage>47</fpage>&#x02013;<lpage>54</lpage>. <pub-id pub-id-type="doi">10.1038/nsmb.3328</pub-id><pub-id pub-id-type="pmid">27870832</pub-id>
</mixed-citation></ref><ref id="bib8"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Cho</surname>, <given-names>A.</given-names></string-name>, <string-name><given-names>C.</given-names><surname>Gaebler</surname></string-name>, <string-name><given-names>T.</given-names><surname>Olveira</surname></string-name>, <string-name><given-names>V.</given-names><surname>Ramos</surname></string-name>, <string-name><given-names>M.</given-names><surname>Saad</surname></string-name>, <string-name><given-names>J.C.C.</given-names><surname>Lorenzi</surname></string-name>, <string-name><given-names>A.</given-names><surname>Gazumyan</surname></string-name>, <string-name><given-names>S.</given-names><surname>Moir</surname></string-name>, <string-name><given-names>M.</given-names><surname>Caskey</surname></string-name>, <string-name><given-names>T.-W.</given-names><surname>Chun</surname></string-name>, and <string-name><given-names>M.C.</given-names><surname>Nussenzweig</surname></string-name></person-group>. <year>2022</year>. <article-title>Longitudinal clonal dynamics of HIV-1 latent reservoirs measured by combination quadruplex polymerase chain reaction and sequencing</article-title>. <source>Proc. Natl. Acad. Sci. USA</source>. <volume>119</volume>:<elocation-id>e2117630119</elocation-id>. <pub-id pub-id-type="doi">10.1073/pnas.2117630119</pub-id><pub-id pub-id-type="pmid">35042816</pub-id>
</mixed-citation></ref><ref id="bib9"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Chomont</surname>, <given-names>N.</given-names></string-name>, <string-name><given-names>M.</given-names><surname>El-Far</surname></string-name>, <string-name><given-names>P.</given-names><surname>Ancuta</surname></string-name>, <string-name><given-names>L.</given-names><surname>Trautmann</surname></string-name>, <string-name><given-names>F.A.</given-names><surname>Procopio</surname></string-name>, <string-name><given-names>B.</given-names><surname>Yassine-Diab</surname></string-name>, <string-name><given-names>G.</given-names><surname>Boucher</surname></string-name>, <string-name><given-names>M.-R.</given-names><surname>Boulassel</surname></string-name>, <string-name><given-names>G.</given-names><surname>Ghattas</surname></string-name>, <string-name><given-names>J.M.</given-names><surname>Brenchley</surname></string-name>, <etal/></person-group>. <year>2009</year>. <article-title>HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation</article-title>. <source>Nat. Med.</source><volume>15</volume>:<fpage>893</fpage>&#x02013;<lpage>900</lpage>. <pub-id pub-id-type="doi">10.1038/nm.1972</pub-id><pub-id pub-id-type="pmid">19543283</pub-id>
</mixed-citation></ref><ref id="bib10"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Chun</surname>, <given-names>T.-W.</given-names></string-name>, <string-name><given-names>D.</given-names><surname>Engel</surname></string-name>, <string-name><given-names>M.M.</given-names><surname>Berrey</surname></string-name>, <string-name><given-names>T.</given-names><surname>Shea</surname></string-name>, <string-name><given-names>L.</given-names><surname>Corey</surname></string-name>, and <string-name><given-names>A.S.</given-names><surname>Fauci</surname></string-name></person-group>. <year>1998</year>. <article-title>Early establishment of a pool of latently infected, resting CD4(+) T cells during primary HIV-1 infection</article-title>. <source>Proc. Natl. Acad. Sci. USA</source>. <volume>95</volume>:<fpage>8869</fpage>&#x02013;<lpage>8873</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.95.15.8869</pub-id><pub-id pub-id-type="pmid">9671771</pub-id>
</mixed-citation></ref><ref id="bib11"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Cohn</surname>, <given-names>L.B.</given-names></string-name>, <string-name><given-names>N.</given-names><surname>Chomont</surname></string-name>, and <string-name><given-names>S.G.</given-names><surname>Deeks</surname></string-name></person-group>. <year>2020</year>. <article-title>The biology of the HIV-1 latent reservoir and implications for cure strategies</article-title>. <source>Cell Host Microbe</source>. <volume>27</volume>:<fpage>519</fpage>&#x02013;<lpage>530</lpage>. <pub-id pub-id-type="doi">10.1016/j.chom.2020.03.014</pub-id><pub-id pub-id-type="pmid">32272077</pub-id>
</mixed-citation></ref><ref id="bib12"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Cohn</surname>, <given-names>L.B.</given-names></string-name>, <string-name><given-names>I.T.</given-names><surname>da Silva</surname></string-name>, <string-name><given-names>R.</given-names><surname>Valieris</surname></string-name>, <string-name><given-names>A.S.</given-names><surname>Huang</surname></string-name>, <string-name><given-names>J.C.C.</given-names><surname>Lorenzi</surname></string-name>, <string-name><given-names>Y.Z.</given-names><surname>Cohen</surname></string-name>, <string-name><given-names>J.A.</given-names><surname>Pai</surname></string-name>, <string-name><given-names>A.L.</given-names><surname>Butler</surname></string-name>, <string-name><given-names>M.</given-names><surname>Caskey</surname></string-name>, <string-name><given-names>M.</given-names><surname>Jankovic</surname></string-name>, and <string-name><given-names>M.C.</given-names><surname>Nussenzweig</surname></string-name></person-group>. <year>2018</year>. <article-title>Clonal CD4<sup>+</sup> T cells in the HIV-1 latent reservoir display a distinct gene profile upon reactivation</article-title>. <source>Nat. Med.</source><volume>24</volume>:<fpage>604</fpage>&#x02013;<lpage>609</lpage>. <pub-id pub-id-type="doi">10.1038/s41591-018-0017-7</pub-id><pub-id pub-id-type="pmid">29686423</pub-id>
</mixed-citation></ref><ref id="bib13"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Cohn</surname>, <given-names>L.B.</given-names></string-name>, <string-name><given-names>I.T.</given-names><surname>Silva</surname></string-name>, <string-name><given-names>T.Y.</given-names><surname>Oliveira</surname></string-name>, <string-name><given-names>R.A.</given-names><surname>Rosales</surname></string-name>, <string-name><given-names>E.H.</given-names><surname>Parrish</surname></string-name>, <string-name><given-names>G.H.</given-names><surname>Learn</surname></string-name>, <string-name><given-names>B.H.</given-names><surname>Hahn</surname></string-name>, <string-name><given-names>J.L.</given-names><surname>Czartoski</surname></string-name>, <string-name><given-names>M.J.</given-names><surname>McElrath</surname></string-name>, <string-name><given-names>C.</given-names><surname>Lehmann</surname></string-name>, <etal/></person-group>. <year>2015</year>. <article-title>HIV-1 integration landscape during latent and active infection</article-title>. <source>Cell</source>. <volume>160</volume>:<fpage>420</fpage>&#x02013;<lpage>432</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2015.01.020</pub-id><pub-id pub-id-type="pmid">25635456</pub-id>
</mixed-citation></ref><ref id="bib14"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Collora</surname>, <given-names>J.A.</given-names></string-name>, and <string-name><given-names>Y.C.</given-names><surname>Ho</surname></string-name></person-group>. <year>2023</year>. <article-title>Integration site-dependent HIV-1 promoter activity shapes host chromatin conformation</article-title>. <source>Genome Res.</source><volume>33</volume>:<fpage>891</fpage>&#x02013;<lpage>906</lpage>. <pub-id pub-id-type="doi">10.1101/gr.277698.123</pub-id><pub-id pub-id-type="pmid">37295842</pub-id>
</mixed-citation></ref><ref id="bib15"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Collora</surname>, <given-names>J.A.</given-names></string-name>, <string-name><given-names>R.</given-names><surname>Liu</surname></string-name>, <string-name><given-names>D.</given-names><surname>Pinto-Santini</surname></string-name>, <string-name><given-names>N.</given-names><surname>Ravindra</surname></string-name>, <string-name><given-names>C.</given-names><surname>Ganoza</surname></string-name>, <string-name><given-names>J.R.</given-names><surname>Lama</surname></string-name>, <string-name><given-names>R.</given-names><surname>Alfaro</surname></string-name>, <string-name><given-names>J.</given-names><surname>Chiarella</surname></string-name>, <string-name><given-names>S.</given-names><surname>Spudich</surname></string-name>, <string-name><given-names>K.</given-names><surname>Mounzer</surname></string-name>, <etal/></person-group>. <year>2022</year>. <article-title>Single-cell multiomics reveals persistence of HIV-1 in expanded cytotoxic T cell clones</article-title>. <source>Immunity</source>. <volume>55</volume>:<fpage>1013</fpage>&#x02013;<lpage>1031.e7</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2022.03.004</pub-id><pub-id pub-id-type="pmid">35320704</pub-id>
</mixed-citation></ref><ref id="bib16"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Craigie</surname>, <given-names>R.</given-names></string-name>, and <string-name><given-names>F.D.</given-names><surname>Bushman</surname></string-name></person-group>. <year>2012</year>. <article-title>HIV DNA integration</article-title>. <source>Cold Spring Harb. Perspect. Med.</source><volume>2</volume>:<fpage>a006890</fpage>. <pub-id pub-id-type="doi">10.1101/cshperspect.a006890</pub-id><pub-id pub-id-type="pmid">22762018</pub-id>
</mixed-citation></ref><ref id="bib17"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Crooks</surname>, <given-names>A.M.</given-names></string-name>, <string-name><given-names>R.</given-names><surname>Bateson</surname></string-name>, <string-name><given-names>A.B.</given-names><surname>Cope</surname></string-name>, <string-name><given-names>N.P.</given-names><surname>Dahl</surname></string-name>, <string-name><given-names>M.K.</given-names><surname>Griggs</surname></string-name>, <string-name><given-names>J.D.</given-names><surname>Kuruc</surname></string-name>, <string-name><given-names>C.L.</given-names><surname>Gay</surname></string-name>, <string-name><given-names>J.J.</given-names><surname>Eron</surname></string-name>, <string-name><given-names>D.M.</given-names><surname>Margolis</surname></string-name>, <string-name><given-names>R.J.</given-names><surname>Bosch</surname></string-name>, and <string-name><given-names>N.M.</given-names><surname>Archin</surname></string-name></person-group>. <year>2015</year>. <article-title>Precise quantitation of the latent HIV-1 reservoir: Implications for eradication strategies</article-title>. <source>J. Infect. Dis.</source><volume>212</volume>:<fpage>1361</fpage>&#x02013;<lpage>1365</lpage>. <pub-id pub-id-type="doi">10.1093/infdis/jiv218</pub-id><pub-id pub-id-type="pmid">25877550</pub-id>
</mixed-citation></ref><ref id="bib18"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Darcis</surname>, <given-names>G.</given-names></string-name>, <string-name><given-names>B.</given-names><surname>Berkhout</surname></string-name>, and <string-name><given-names>A.O.</given-names><surname>Pasternak</surname></string-name></person-group>. <year>2019</year>. <article-title>The quest for cellular markers of HIV reservoirs: Any color you like</article-title>. <source>Front. Immunol.</source><volume>10</volume>:<fpage>2251</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2019.02251</pub-id><pub-id pub-id-type="pmid">31616425</pub-id>
</mixed-citation></ref><ref id="bib19"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Demoustier</surname>, <given-names>A.</given-names></string-name>, <string-name><given-names>B.</given-names><surname>Gubler</surname></string-name>, <string-name><given-names>O.</given-names><surname>Lambotte</surname></string-name>, <string-name><given-names>M.G.</given-names><surname>de Goer</surname></string-name>, <string-name><given-names>C.</given-names><surname>Wallon</surname></string-name>, <string-name><given-names>C.</given-names><surname>Goujard</surname></string-name>, <string-name><given-names>J.F.</given-names><surname>Delfraissy</surname></string-name>, and <string-name><given-names>Y.</given-names><surname>Taoufik</surname></string-name></person-group>. <year>2002</year>. <article-title>In patients on prolonged HAART, a significant pool of HIV infected CD4 T cells are HIV-specific</article-title>. <source>AIDS</source>. <volume>16</volume>:<fpage>1749</fpage>&#x02013;<lpage>1754</lpage>. <pub-id pub-id-type="doi">10.1097/00002030-200209060-00006</pub-id><pub-id pub-id-type="pmid">12218385</pub-id>
</mixed-citation></ref><ref id="bib20"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Douek</surname>, <given-names>D.C.</given-names></string-name>, <string-name><given-names>J.M.</given-names><surname>Brenchley</surname></string-name>, <string-name><given-names>M.R.</given-names><surname>Betts</surname></string-name>, <string-name><given-names>D.R.</given-names><surname>Ambrozak</surname></string-name>, <string-name><given-names>B.J.</given-names><surname>Hill</surname></string-name>, <string-name><given-names>Y.</given-names><surname>Okamoto</surname></string-name>, <string-name><given-names>J.P.</given-names><surname>Casazza</surname></string-name>, <string-name><given-names>J.</given-names><surname>Kuruppu</surname></string-name>, <string-name><given-names>K.</given-names><surname>Kunstman</surname></string-name>, <string-name><given-names>S.</given-names><surname>Wolinsky</surname></string-name>, <etal/></person-group>. <year>2002</year>. <article-title>HIV preferentially infects HIV-specific CD4<sup>+</sup> T cells</article-title>. <source>Nature</source>. <volume>417</volume>:<fpage>95</fpage>&#x02013;<lpage>98</lpage>. <pub-id pub-id-type="doi">10.1038/417095a</pub-id><pub-id pub-id-type="pmid">11986671</pub-id>
</mixed-citation></ref><ref id="bib21"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Dufour</surname>, <given-names>C.</given-names></string-name>, <string-name><given-names>P.</given-names><surname>Gantner</surname></string-name>, <string-name><given-names>R.</given-names><surname>Fromentin</surname></string-name>, and <string-name><given-names>N.</given-names><surname>Chomont</surname></string-name></person-group>. <year>2021</year>. <article-title>The multifaceted nature of HIV latency</article-title>. <source>J. Clin. Invest.</source><volume>131</volume>:<elocation-id>e151380</elocation-id>. <pub-id pub-id-type="doi">10.1172/JCI151380</pub-id><pub-id pub-id-type="pmid">34060493</pub-id>
</mixed-citation></ref><ref id="bib22"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Einkauf</surname>, <given-names>K.B.</given-names></string-name>, <string-name><given-names>G.Q.</given-names><surname>Lee</surname></string-name>, <string-name><given-names>C.</given-names><surname>Gao</surname></string-name>, <string-name><given-names>R.</given-names><surname>Sharaf</surname></string-name>, <string-name><given-names>X.</given-names><surname>Sun</surname></string-name>, <string-name><given-names>S.</given-names><surname>Hua</surname></string-name>, <string-name><given-names>S.M.Y.</given-names><surname>Chen</surname></string-name>, <string-name><given-names>C.</given-names><surname>Jiang</surname></string-name>, <string-name><given-names>X.</given-names><surname>Lian</surname></string-name>, <string-name><given-names>F.Z.</given-names><surname>Chowdhury</surname></string-name>, <etal/></person-group>. <year>2019</year>. <article-title>Intact HIV-1 proviruses accumulate at distinct chromosomal positions during prolonged antiretroviral therapy</article-title>. <source>J. Clin. Invest.</source><volume>129</volume>:<fpage>988</fpage>&#x02013;<lpage>998</lpage>. <pub-id pub-id-type="doi">10.1172/JCI124291</pub-id><pub-id pub-id-type="pmid">30688658</pub-id>
</mixed-citation></ref><ref id="bib23"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Einkauf</surname>, <given-names>K.B.</given-names></string-name>, <string-name><given-names>M.R.</given-names><surname>Osborn</surname></string-name>, <string-name><given-names>C.</given-names><surname>Gao</surname></string-name>, <string-name><given-names>W.</given-names><surname>Sun</surname></string-name>, <string-name><given-names>X.</given-names><surname>Sun</surname></string-name>, <string-name><given-names>X.</given-names><surname>Lian</surname></string-name>, <string-name><given-names>E.M.</given-names><surname>Parsons</surname></string-name>, <string-name><given-names>G.T.</given-names><surname>Gladkov</surname></string-name>, <string-name><given-names>K.W.</given-names><surname>Seiger</surname></string-name>, <string-name><given-names>J.E.</given-names><surname>Blackmer</surname></string-name>, <etal/></person-group>. <year>2022</year>. <article-title>Parallel analysis of transcription, integration, and sequence of single HIV-1 proviruses</article-title>. <source>Cell</source>. <volume>185</volume>:<fpage>266</fpage>&#x02013;<lpage>282.e15</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2021.12.011</pub-id><pub-id pub-id-type="pmid">35026153</pub-id>
</mixed-citation></ref><ref id="bib24"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Finzi</surname>, <given-names>D.</given-names></string-name>, <string-name><given-names>J.</given-names><surname>Blankson</surname></string-name>, <string-name><given-names>J.D.</given-names><surname>Siliciano</surname></string-name>, <string-name><given-names>J.B.</given-names><surname>Margolick</surname></string-name>, <string-name><given-names>K.</given-names><surname>Chadwick</surname></string-name>, <string-name><given-names>T.</given-names><surname>Pierson</surname></string-name>, <string-name><given-names>K.</given-names><surname>Smith</surname></string-name>, <string-name><given-names>J.</given-names><surname>Lisziewicz</surname></string-name>, <string-name><given-names>F.</given-names><surname>Lori</surname></string-name>, <string-name><given-names>C.</given-names><surname>Flexner</surname></string-name>, <etal/></person-group>. <year>1999</year>. <article-title>Latent infection of CD4<sup>+</sup> T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy</article-title>. <source>Nat. Med.</source><volume>5</volume>:<fpage>512</fpage>&#x02013;<lpage>517</lpage>. <pub-id pub-id-type="doi">10.1038/8394</pub-id><pub-id pub-id-type="pmid">10229227</pub-id>
</mixed-citation></ref><ref id="bib25"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Gaebler</surname>, <given-names>C.</given-names></string-name>, <string-name><given-names>J.C.C.</given-names><surname>Lorenzi</surname></string-name>, <string-name><given-names>T.Y.</given-names><surname>Oliveira</surname></string-name>, <string-name><given-names>L.</given-names><surname>Nogueira</surname></string-name>, <string-name><given-names>V.</given-names><surname>Ramos</surname></string-name>, <string-name><given-names>C.L.</given-names><surname>Lu</surname></string-name>, <string-name><given-names>J.A.</given-names><surname>Pai</surname></string-name>, <string-name><given-names>P.</given-names><surname>Mendoza</surname></string-name>, <string-name><given-names>M.</given-names><surname>Jankovic</surname></string-name>, <string-name><given-names>M.</given-names><surname>Caskey</surname></string-name>, and <string-name><given-names>M.C.</given-names><surname>Nussenzweig</surname></string-name></person-group>. <year>2019</year>. <article-title>Combination of quadruplex qPCR and next-generation sequencing for qualitative and quantitative analysis of the HIV-1 latent reservoir</article-title>. <source>J. Exp. Med.</source><volume>216</volume>:<fpage>2253</fpage>&#x02013;<lpage>2264</lpage>. <pub-id pub-id-type="doi">10.1084/jem.20190896</pub-id><pub-id pub-id-type="pmid">31350309</pub-id>
</mixed-citation></ref><ref id="bib26"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Gibson</surname>, <given-names>D.G.</given-names></string-name>, <string-name><given-names>L.</given-names><surname>Young</surname></string-name>, <string-name><given-names>R.-Y.</given-names><surname>Chuang</surname></string-name>, <string-name><given-names>J.C.</given-names><surname>Venter</surname></string-name>, <string-name><given-names>C.A.</given-names><surname>Hutchison</surname><suffix>III</suffix></string-name>, and <string-name><given-names>H.O.</given-names><surname>Smith</surname></string-name></person-group>. <year>2009</year>. <article-title>Enzymatic assembly of DNA molecules up to several hundred kilobases</article-title>. <source>Nat. Methods</source>. <volume>6</volume>:<fpage>343</fpage>&#x02013;<lpage>345</lpage>. <pub-id pub-id-type="doi">10.1038/nmeth.1318</pub-id><pub-id pub-id-type="pmid">19363495</pub-id>
</mixed-citation></ref><ref id="bib27"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Han</surname>, <given-names>Y.</given-names></string-name>, <string-name><given-names>K.</given-names><surname>Lassen</surname></string-name>, <string-name><given-names>D.</given-names><surname>Monie</surname></string-name>, <string-name><given-names>A.R.</given-names><surname>Sedaghat</surname></string-name>, <string-name><given-names>S.</given-names><surname>Shimoji</surname></string-name>, <string-name><given-names>X.</given-names><surname>Liu</surname></string-name>, <string-name><given-names>T.C.</given-names><surname>Pierson</surname></string-name>, <string-name><given-names>J.B.</given-names><surname>Margolick</surname></string-name>, <string-name><given-names>R.F.</given-names><surname>Siliciano</surname></string-name>, and <string-name><given-names>J.D.</given-names><surname>Siliciano</surname></string-name></person-group>. <year>2004</year>. <article-title>Resting CD4<sup>+</sup> T cells from human immunodeficiency virus type 1 (HIV-1)-infected individuals carry integrated HIV-1 genomes within actively transcribed host genes</article-title>. <source>J. Virol.</source><volume>78</volume>:<fpage>6122</fpage>&#x02013;<lpage>6133</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.78.12.6122-6133.2004</pub-id><pub-id pub-id-type="pmid">15163705</pub-id>
</mixed-citation></ref><ref id="bib28"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Hartweger</surname>, <given-names>H.</given-names></string-name>, <string-name><given-names>R.</given-names><surname>Gautam</surname></string-name>, <string-name><given-names>Y.</given-names><surname>Nishimura</surname></string-name>, <string-name><given-names>F.</given-names><surname>Schmidt</surname></string-name>, <string-name><given-names>K.-H.</given-names><surname>Yao</surname></string-name>, <string-name><given-names>A.</given-names><surname>Escolano</surname></string-name>, <string-name><given-names>M.</given-names><surname>Jankovic</surname></string-name>, <string-name><given-names>M.A.</given-names><surname>Martin</surname></string-name>, and <string-name><given-names>M.C.</given-names><surname>Nussenzweig</surname></string-name></person-group>. <year>2023</year>. <article-title>Gene editing of primary rhesus macaque B cells</article-title>. <source>J. Vis. Exp.</source><volume>192</volume>:<elocation-id>e64858</elocation-id>. <pub-id pub-id-type="doi">10.3791/64858</pub-id></mixed-citation></ref><ref id="bib29"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Ho</surname>, <given-names>Y.-C.</given-names></string-name>, <string-name><given-names>L.</given-names><surname>Shan</surname></string-name>, <string-name><given-names>N.N.</given-names><surname>Hosmane</surname></string-name>, <string-name><given-names>J.</given-names><surname>Wang</surname></string-name>, <string-name><given-names>S.B.</given-names><surname>Laskey</surname></string-name>, <string-name><given-names>D.I.S.</given-names><surname>Rosenbloom</surname></string-name>, <string-name><given-names>J.</given-names><surname>Lai</surname></string-name>, <string-name><given-names>J.N.</given-names><surname>Blankson</surname></string-name>, <string-name><given-names>J.D.</given-names><surname>Siliciano</surname></string-name>, and <string-name><given-names>R.F.</given-names><surname>Siliciano</surname></string-name></person-group>. <year>2013</year>. <article-title>Replication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure</article-title>. <source>Cell</source>. <volume>155</volume>:<fpage>540</fpage>&#x02013;<lpage>551</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2013.09.020</pub-id><pub-id pub-id-type="pmid">24243014</pub-id>
</mixed-citation></ref><ref id="bib30"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Hosmane</surname>, <given-names>N.N.</given-names></string-name>, <string-name><given-names>K.J.</given-names><surname>Kwon</surname></string-name>, <string-name><given-names>K.M.</given-names><surname>Bruner</surname></string-name>, <string-name><given-names>A.A.</given-names><surname>Capoferri</surname></string-name>, <string-name><given-names>S.</given-names><surname>Beg</surname></string-name>, <string-name><given-names>D.I.S.</given-names><surname>Rosenbloom</surname></string-name>, <string-name><given-names>B.F.</given-names><surname>Keele</surname></string-name>, <string-name><given-names>Y.-C.</given-names><surname>Ho</surname></string-name>, <string-name><given-names>J.D.</given-names><surname>Siliciano</surname></string-name>, and <string-name><given-names>R.F.</given-names><surname>Siliciano</surname></string-name></person-group>. <year>2017</year>. <article-title>Proliferation of latently infected CD4<sup>+</sup> T cells carrying replication-competent HIV-1: Potential role in latent reservoir dynamics</article-title>. <source>J. Exp. Med.</source><volume>214</volume>:<fpage>959</fpage>&#x02013;<lpage>972</lpage>. <pub-id pub-id-type="doi">10.1084/jem.20170193</pub-id><pub-id pub-id-type="pmid">28341641</pub-id>
</mixed-citation></ref><ref id="bib31"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Huang</surname>, <given-names>A.S.</given-names></string-name>, <string-name><given-names>V.</given-names><surname>Ramos</surname></string-name>, <string-name><given-names>T.Y.</given-names><surname>Oliveira</surname></string-name>, <string-name><given-names>C.</given-names><surname>Gaebler</surname></string-name>, <string-name><given-names>M.</given-names><surname>Jankovic</surname></string-name>, <string-name><given-names>M.C.</given-names><surname>Nussenzweig</surname></string-name>, and <string-name><given-names>L.B.</given-names><surname>Cohn</surname></string-name></person-group>. <year>2021</year>. <article-title>Integration features of intact latent HIV-1 in CD4<sup>+</sup> T cell clones contribute to viral persistence</article-title>. <source>J. Exp. Med.</source><volume>218</volume>:<elocation-id>e20211427</elocation-id>. <pub-id pub-id-type="doi">10.1084/jem.20211427</pub-id><pub-id pub-id-type="pmid">34636876</pub-id>
</mixed-citation></ref><ref id="bib32"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Hultquist</surname>, <given-names>J.F.</given-names></string-name>, <string-name><given-names>J.</given-names><surname>Hiatt</surname></string-name>, <string-name><given-names>K.</given-names><surname>Schumann</surname></string-name>, <string-name><given-names>M.J.</given-names><surname>McGregor</surname></string-name>, <string-name><given-names>T.L.</given-names><surname>Roth</surname></string-name>, <string-name><given-names>P.</given-names><surname>Haas</surname></string-name>, <string-name><given-names>J.A.</given-names><surname>Doudna</surname></string-name>, <string-name><given-names>A.</given-names><surname>Marson</surname></string-name>, and <string-name><given-names>N.J.</given-names><surname>Krogan</surname></string-name></person-group>. <year>2019</year>. <article-title>CRISPR-Cas9 genome engineering of primary CD4(+) T cells for the interrogation of HIV-host factor interactions</article-title>. <source>Nat. Protoc.</source><volume>14</volume>:<fpage>1</fpage>&#x02013;<lpage>27</lpage>. <pub-id pub-id-type="doi">10.1038/s41596-018-0069-7</pub-id><pub-id pub-id-type="pmid">30559373</pub-id>
</mixed-citation></ref><ref id="bib33"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Jiang</surname>, <given-names>C.</given-names></string-name>, <string-name><given-names>X.</given-names><surname>Lian</surname></string-name>, <string-name><given-names>C.</given-names><surname>Gao</surname></string-name>, <string-name><given-names>X.</given-names><surname>Sun</surname></string-name>, <string-name><given-names>K.B.</given-names><surname>Einkauf</surname></string-name>, <string-name><given-names>J.M.</given-names><surname>Chevalier</surname></string-name>, <string-name><given-names>S.M.Y.</given-names><surname>Chen</surname></string-name>, <string-name><given-names>S.</given-names><surname>Hua</surname></string-name>, <string-name><given-names>B.</given-names><surname>Rhee</surname></string-name>, <string-name><given-names>K.</given-names><surname>Chang</surname></string-name>, <etal/></person-group>. <year>2020</year>. <article-title>Distinct viral reservoirs in individuals with spontaneous control of HIV-1</article-title>. <source>Nature</source>. <volume>585</volume>:<fpage>261</fpage>&#x02013;<lpage>267</lpage>. <pub-id pub-id-type="doi">10.1038/s41586-020-2651-8</pub-id><pub-id pub-id-type="pmid">32848246</pub-id>
</mixed-citation></ref><ref id="bib34"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Jones</surname>, <given-names>R.B.</given-names></string-name>, <string-name><given-names>C.</given-names><surname>Kovacs</surname></string-name>, <string-name><given-names>T.W.</given-names><surname>Chun</surname></string-name>, and <string-name><given-names>M.A.</given-names><surname>Ostrowski</surname></string-name></person-group>. <year>2012</year>. <article-title>Short communication: HIV type 1 accumulates in influenza-specific T cells in subjects receiving seasonal vaccination in the context of effective antiretroviral therapy</article-title>. <source>AIDS Res. Hum. Retroviruses</source>. <volume>28</volume>:<fpage>1687</fpage>&#x02013;<lpage>1692</lpage>. <pub-id pub-id-type="doi">10.1089/aid.2012.0115</pub-id><pub-id pub-id-type="pmid">22734882</pub-id>
</mixed-citation></ref><ref id="bib35"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Jones</surname>, <given-names>R.B.</given-names></string-name>, <string-name><given-names>S.</given-names><surname>Mueller</surname></string-name>, <string-name><given-names>R.</given-names><surname>O&#x02019;Connor</surname></string-name>, <string-name><given-names>K.</given-names><surname>Rimpel</surname></string-name>, <string-name><given-names>D.D.</given-names><surname>Sloan</surname></string-name>, <string-name><given-names>D.</given-names><surname>Karel</surname></string-name>, <string-name><given-names>H.C.</given-names><surname>Wong</surname></string-name>, <string-name><given-names>E.K.</given-names><surname>Jeng</surname></string-name>, <string-name><given-names>A.S.</given-names><surname>Thomas</surname></string-name>, <string-name><given-names>J.B.</given-names><surname>Whitney</surname></string-name>, <etal/></person-group>. <year>2016</year>. <article-title>A subset of latency-reversing agents expose HIV-infected resting CD4<sup>+</sup> T-cells to recognition by cytotoxic T-lymphocytes</article-title>. <source>PLoS Pathog.</source><volume>12</volume>:<elocation-id>e1005545</elocation-id>. <pub-id pub-id-type="doi">10.1371/journal.ppat.1005545</pub-id><pub-id pub-id-type="pmid">27082643</pub-id>
</mixed-citation></ref><ref id="bib36"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Jordan</surname>, <given-names>A.</given-names></string-name>, <string-name><given-names>D.</given-names><surname>Bisgrove</surname></string-name>, and <string-name><given-names>E.</given-names><surname>Verdin</surname></string-name></person-group>. <year>2003</year>. <article-title>HIV reproducibly establishes a latent infection after acute infection of T cells in vitro</article-title>. <source>EMBO J.</source><volume>22</volume>:<fpage>1868</fpage>&#x02013;<lpage>1877</lpage>. <pub-id pub-id-type="doi">10.1093/emboj/cdg188</pub-id><pub-id pub-id-type="pmid">12682019</pub-id>
</mixed-citation></ref><ref id="bib37"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Jordan</surname>, <given-names>A.</given-names></string-name>, <string-name><given-names>P.</given-names><surname>Defechereux</surname></string-name>, and <string-name><given-names>E.</given-names><surname>Verdin</surname></string-name></person-group>. <year>2001</year>. <article-title>The site of HIV-1 integration in the human genome determines basal transcriptional activity and response to Tat transactivation</article-title>. <source>EMBO J.</source><volume>20</volume>:<fpage>1726</fpage>&#x02013;<lpage>1738</lpage>. <pub-id pub-id-type="doi">10.1093/emboj/20.7.1726</pub-id><pub-id pub-id-type="pmid">11285236</pub-id>
</mixed-citation></ref><ref id="bib38"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Lee</surname>, <given-names>G.Q.</given-names></string-name>, <string-name><given-names>N.</given-names><surname>Orlova-Fink</surname></string-name>, <string-name><given-names>K.</given-names><surname>Einkauf</surname></string-name>, <string-name><given-names>F.Z.</given-names><surname>Chowdhury</surname></string-name>, <string-name><given-names>X.</given-names><surname>Sun</surname></string-name>, <string-name><given-names>S.</given-names><surname>Harrington</surname></string-name>, <string-name><given-names>H.H.</given-names><surname>Kuo</surname></string-name>, <string-name><given-names>S.</given-names><surname>Hua</surname></string-name>, <string-name><given-names>H.R.</given-names><surname>Chen</surname></string-name>, <string-name><given-names>Z.</given-names><surname>Ouyang</surname></string-name>, <etal/></person-group>. <year>2017</year>. <article-title>Clonal expansion of genome-intact HIV-1 in functionally polarized Th1 CD4<sup>+</sup> T cells</article-title>. <source>J. Clin. Invest.</source><volume>127</volume>:<fpage>2689</fpage>&#x02013;<lpage>2696</lpage>. <pub-id pub-id-type="doi">10.1172/JCI93289</pub-id><pub-id pub-id-type="pmid">28628034</pub-id>
</mixed-citation></ref><ref id="bib39"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Lewinski</surname>, <given-names>M.K.</given-names></string-name>, <string-name><given-names>D.</given-names><surname>Bisgrove</surname></string-name>, <string-name><given-names>P.</given-names><surname>Shinn</surname></string-name>, <string-name><given-names>H.</given-names><surname>Chen</surname></string-name>, <string-name><given-names>C.</given-names><surname>Hoffmann</surname></string-name>, <string-name><given-names>S.</given-names><surname>Hannenhalli</surname></string-name>, <string-name><given-names>E.</given-names><surname>Verdin</surname></string-name>, <string-name><given-names>C.C.</given-names><surname>Berry</surname></string-name>, <string-name><given-names>J.R.</given-names><surname>Ecker</surname></string-name>, and <string-name><given-names>F.D.</given-names><surname>Bushman</surname></string-name></person-group>. <year>2005</year>. <article-title>Genome-wide analysis of chromosomal features repressing human immunodeficiency virus transcription</article-title>. <source>J. Virol.</source><volume>79</volume>:<fpage>6610</fpage>&#x02013;<lpage>6619</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.79.11.6610-6619.2005</pub-id><pub-id pub-id-type="pmid">15890899</pub-id>
</mixed-citation></ref><ref id="bib40"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Li</surname>, <given-names>J.Z.</given-names></string-name>, <string-name><given-names>B.</given-names><surname>Etemad</surname></string-name>, <string-name><given-names>H.</given-names><surname>Ahmed</surname></string-name>, <string-name><given-names>E.</given-names><surname>Aga</surname></string-name>, <string-name><given-names>R.J.</given-names><surname>Bosch</surname></string-name>, <string-name><given-names>J.W.</given-names><surname>Mellors</surname></string-name>, <string-name><given-names>D.R.</given-names><surname>Kuritzkes</surname></string-name>, <string-name><given-names>M.M.</given-names><surname>Lederman</surname></string-name>, <string-name><given-names>M.</given-names><surname>Para</surname></string-name>, and <string-name><given-names>R.T.</given-names><surname>Gandhi</surname></string-name></person-group>. <year>2016</year>. <article-title>The size of the expressed HIV reservoir predicts timing of viral rebound after treatment interruption</article-title>. <source>AIDS</source>. <volume>30</volume>:<fpage>343</fpage>&#x02013;<lpage>353</lpage>. <pub-id pub-id-type="doi">10.1097/QAD.0000000000000953</pub-id><pub-id pub-id-type="pmid">26588174</pub-id>
</mixed-citation></ref><ref id="bib41"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Lichterfeld</surname>, <given-names>M.</given-names></string-name>, <string-name><given-names>C.</given-names><surname>Gao</surname></string-name>, and <string-name><given-names>X.G.</given-names><surname>Yu</surname></string-name></person-group>. <year>2022</year>. <article-title>An ordeal that does not heal: Understanding barriers to a cure for HIV-1 infection</article-title>. <source>Trends Immunol.</source><volume>43</volume>:<fpage>608</fpage>&#x02013;<lpage>616</lpage>. <pub-id pub-id-type="doi">10.1016/j.it.2022.06.002</pub-id><pub-id pub-id-type="pmid">35905706</pub-id>
</mixed-citation></ref><ref id="bib42"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Liu</surname>, <given-names>R.</given-names></string-name>, <string-name><given-names>F.R.</given-names><surname>Simonetti</surname></string-name>, and <string-name><given-names>Y.-C.</given-names><surname>Ho</surname></string-name></person-group>. <year>2020</year>. <article-title>The forces driving clonal expansion of the HIV-1 latent reservoir</article-title>. <source>Virol. J.</source><volume>17</volume>:<fpage>4</fpage>. <pub-id pub-id-type="doi">10.1186/s12985-019-1276-8</pub-id><pub-id pub-id-type="pmid">31910871</pub-id>
</mixed-citation></ref><ref id="bib43"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Lorenzi</surname>, <given-names>J.C.C.</given-names></string-name>, <string-name><given-names>Y.Z.</given-names><surname>Cohen</surname></string-name>, <string-name><given-names>L.B.</given-names><surname>Cohn</surname></string-name>, <string-name><given-names>E.F.</given-names><surname>Kreider</surname></string-name>, <string-name><given-names>J.P.</given-names><surname>Barton</surname></string-name>, <string-name><given-names>G.H.</given-names><surname>Learn</surname></string-name>, <string-name><given-names>T.</given-names><surname>Oliveira</surname></string-name>, <string-name><given-names>C.L.</given-names><surname>Lavine</surname></string-name>, <string-name><given-names>J.A.</given-names><surname>Horwitz</surname></string-name>, <string-name><given-names>A.</given-names><surname>Settler</surname></string-name>, <etal/></person-group>. <year>2016</year>. <article-title>Paired quantitative and qualitative assessment of the replication-competent HIV-1 reservoir and comparison with integrated proviral DNA</article-title>. <source>Proc. Natl. Acad. Sci. USA</source>. <volume>113</volume>:<fpage>E7908</fpage>&#x02013;<lpage>E7916</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1617789113</pub-id><pub-id pub-id-type="pmid">27872306</pub-id>
</mixed-citation></ref><ref id="bib44"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Lu</surname>, <given-names>C.-L.</given-names></string-name>, <string-name><given-names>J.A.</given-names><surname>Pai</surname></string-name>, <string-name><given-names>L.</given-names><surname>Nogueira</surname></string-name>, <string-name><given-names>P.</given-names><surname>Mendoza</surname></string-name>, <string-name><given-names>H.</given-names><surname>Gruell</surname></string-name>, <string-name><given-names>T.Y.</given-names><surname>Oliveira</surname></string-name>, <string-name><given-names>J.</given-names><surname>Barton</surname></string-name>, <string-name><given-names>J.C.C.</given-names><surname>Lorenzi</surname></string-name>, <string-name><given-names>Y.Z.</given-names><surname>Cohen</surname></string-name>, <string-name><given-names>L.B.</given-names><surname>Cohn</surname></string-name>, <etal/></person-group>. <year>2018</year>. <article-title>Relationship between intact HIV-1 proviruses in circulating CD4<sup>+</sup> T cells and rebound viruses emerging during treatment interruption</article-title>. <source>Proc. Natl. Acad. Sci. USA</source>. <volume>115</volume>:<fpage>E11341</fpage>&#x02013;<lpage>E11348</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1813512115</pub-id><pub-id pub-id-type="pmid">30420517</pub-id>
</mixed-citation></ref><ref id="bib45"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Malim</surname>, <given-names>M.H.</given-names></string-name>, and <string-name><given-names>M.</given-names><surname>Emerman</surname></string-name></person-group>. <year>2008</year>. <article-title>HIV-1 accessory proteins--ensuring viral survival in a hostile environment</article-title>. <source>Cell Host Microbe</source>. <volume>3</volume>:<fpage>388</fpage>&#x02013;<lpage>398</lpage>. <pub-id pub-id-type="doi">10.1016/j.chom.2008.04.008</pub-id><pub-id pub-id-type="pmid">18541215</pub-id>
</mixed-citation></ref><ref id="bib46"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Margolis</surname>, <given-names>D.M.</given-names></string-name>, and <string-name><given-names>N.M.</given-names><surname>Archin</surname></string-name></person-group>. <year>2017</year>. <article-title>Proviral latency, persistent human immunodeficiency virus infection, and the development of latency reversing agents</article-title>. <source>J. Infect. Dis.</source><volume>215</volume>:<fpage>S111</fpage>&#x02013;<lpage>S118</lpage>. <pub-id pub-id-type="doi">10.1093/infdis/jiw618</pub-id><pub-id pub-id-type="pmid">28520964</pub-id>
</mixed-citation></ref><ref id="bib47"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Martin</surname>, <given-names>R.M.</given-names></string-name>, <string-name><given-names>K.</given-names><surname>Ikeda</surname></string-name>, <string-name><given-names>M.K.</given-names><surname>Cromer</surname></string-name>, <string-name><given-names>N.</given-names><surname>Uchida</surname></string-name>, <string-name><given-names>T.</given-names><surname>Nishimura</surname></string-name>, <string-name><given-names>R.</given-names><surname>Romano</surname></string-name>, <string-name><given-names>A.J.</given-names><surname>Tong</surname></string-name>, <string-name><given-names>V.T.</given-names><surname>Lemgart</surname></string-name>, <string-name><given-names>J.</given-names><surname>Camarena</surname></string-name>, <string-name><given-names>M.</given-names><surname>Pavel-Dinu</surname></string-name>, <etal/></person-group>. <year>2019</year>. <article-title>Highly efficient and marker-free genome editing of human pluripotent stem cells by CRISPR-Cas9 RNP and AAV6 donor-mediated homologous recombination</article-title>. <source>Cell Stem Cell</source>. <volume>24</volume>:<fpage>821</fpage>&#x02013;<lpage>828.e5</lpage>. <pub-id pub-id-type="doi">10.1016/j.stem.2019.04.001</pub-id><pub-id pub-id-type="pmid">31051134</pub-id>
</mixed-citation></ref><ref id="bib48"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Mendoza</surname>, <given-names>P.</given-names></string-name>, <string-name><given-names>J.R.</given-names><surname>Jackson</surname></string-name>, <string-name><given-names>T.Y.</given-names><surname>Oliveira</surname></string-name>, <string-name><given-names>C.</given-names><surname>Gaebler</surname></string-name>, <string-name><given-names>V.</given-names><surname>Ramos</surname></string-name>, <string-name><given-names>M.</given-names><surname>Caskey</surname></string-name>, <string-name><given-names>M.</given-names><surname>Jankovic</surname></string-name>, <string-name><given-names>M.C.</given-names><surname>Nussenzweig</surname></string-name>, and <string-name><given-names>L.B.</given-names><surname>Cohn</surname></string-name></person-group>. <year>2020</year>. <article-title>Antigen-responsive CD4<sup>+</sup> T cell clones contribute to the HIV-1 latent reservoir</article-title>. <source>J. Exp. Med.</source><volume>217</volume>:<elocation-id>e20200051</elocation-id>. <pub-id pub-id-type="doi">10.1084/jem.20200051</pub-id><pub-id pub-id-type="pmid">32311008</pub-id>
</mixed-citation></ref><ref id="bib49"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Mori</surname>, <given-names>L.</given-names></string-name>, and <string-name><given-names>S.T.</given-names><surname>Valente</surname></string-name></person-group>. <year>2020</year>. <article-title>Key players in HIV-1 transcriptional regulation: Targets for a functional cure</article-title>. <source>Viruses</source>. <volume>12</volume>:<fpage>529</fpage>. <pub-id pub-id-type="doi">10.3390/v12050529</pub-id><pub-id pub-id-type="pmid">32403278</pub-id>
</mixed-citation></ref><ref id="bib50"><mixed-citation publication-type="book">
<person-group person-group-type="author">
<string-name>
<surname>Ne</surname>, <given-names>E.</given-names></string-name>, <string-name><given-names>R.-J.</given-names><surname>Palstra</surname></string-name>, and <string-name><given-names>T.</given-names><surname>Mahmoudi</surname></string-name></person-group>. <year>2018</year>. <article-title>Chapter six&#x02014;transcription: Insights from the HIV-1 promoter</article-title>. <italic toggle="yes">In</italic><source>International Review of Cell and Molecular Biology</source>. <volume>Vol. 335</volume>. <person-group person-group-type="editor"><string-name><given-names>F.</given-names><surname>Loos</surname></string-name></person-group>, editor. <publisher-name>Academic Press</publisher-name>, <publisher-loc>Cambridge, MA, USA</publisher-loc>. <fpage>191</fpage>&#x02013;<lpage>243</lpage>. <pub-id pub-id-type="doi">10.1016/bs.ircmb.2017.07.011</pub-id></mixed-citation></ref><ref id="bib51"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Pace</surname>, <given-names>M.J.</given-names></string-name>, <string-name><given-names>L.</given-names><surname>Agosto</surname></string-name>, <string-name><given-names>E.H.</given-names><surname>Graf</surname></string-name>, and <string-name><given-names>U.</given-names><surname>O&#x02019;Doherty</surname></string-name></person-group>. <year>2011</year>. <article-title>HIV reservoirs and latency models</article-title>. <source>Virology</source>. <volume>411</volume>:<fpage>344</fpage>&#x02013;<lpage>354</lpage>. <pub-id pub-id-type="doi">10.1016/j.virol.2010.12.041</pub-id><pub-id pub-id-type="pmid">21284992</pub-id>
</mixed-citation></ref><ref id="bib52"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Palmer</surname>, <given-names>S.</given-names></string-name>, <string-name><given-names>A.P.</given-names><surname>Wiegand</surname></string-name>, <string-name><given-names>F.</given-names><surname>Maldarelli</surname></string-name>, <string-name><given-names>H.</given-names><surname>Bazmi</surname></string-name>, <string-name><given-names>J.M.</given-names><surname>Mican</surname></string-name>, <string-name><given-names>M.</given-names><surname>Polis</surname></string-name>, <string-name><given-names>R.L.</given-names><surname>Dewar</surname></string-name>, <string-name><given-names>A.</given-names><surname>Planta</surname></string-name>, <string-name><given-names>S.</given-names><surname>Liu</surname></string-name>, <string-name><given-names>J.A.</given-names><surname>Metcalf</surname></string-name>, <etal/></person-group>. <year>2003</year>. <article-title>New real-time reverse transcriptase-initiated PCR assay with single-copy sensitivity for human immunodeficiency virus type 1 RNA in plasma</article-title>. <source>J. Clin. Microbiol.</source><volume>41</volume>:<fpage>4531</fpage>&#x02013;<lpage>4536</lpage>. <pub-id pub-id-type="doi">10.1128/JCM.41.10.4531-4536.2003</pub-id><pub-id pub-id-type="pmid">14532178</pub-id>
</mixed-citation></ref><ref id="bib53"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Peluso</surname>, <given-names>M.J.</given-names></string-name>, <string-name><given-names>P.</given-names><surname>Bacchetti</surname></string-name>, <string-name><given-names>K.D.</given-names><surname>Ritter</surname></string-name>, <string-name><given-names>S.</given-names><surname>Beg</surname></string-name>, <string-name><given-names>J.</given-names><surname>Lai</surname></string-name>, <string-name><given-names>J.N.</given-names><surname>Martin</surname></string-name>, <string-name><given-names>P.W.</given-names><surname>Hunt</surname></string-name>, <string-name><given-names>T.J.</given-names><surname>Henrich</surname></string-name>, <string-name><given-names>J.D.</given-names><surname>Siliciano</surname></string-name>, <string-name><given-names>R.F.</given-names><surname>Siliciano</surname></string-name>, <etal/></person-group>. <year>2020</year>. <article-title>Differential decay of intact and defective proviral DNA in HIV-1&#x02013;infected individuals on suppressive antiretroviral therapy</article-title>. <source>JCI Insight</source><volume>5</volume>:<elocation-id>e132997</elocation-id>. <pub-id pub-id-type="doi">10.1172/jci.insight.132997</pub-id><pub-id pub-id-type="pmid">32045386</pub-id>
</mixed-citation></ref><ref id="bib54"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Perelson</surname>, <given-names>A.S.</given-names></string-name>, <string-name><given-names>A.U.</given-names><surname>Neumann</surname></string-name>, <string-name><given-names>M.</given-names><surname>Markowitz</surname></string-name>, <string-name><given-names>J.M.</given-names><surname>Leonard</surname></string-name>, and <string-name><given-names>D.D.</given-names><surname>Ho</surname></string-name></person-group>. <year>1996</year>. <article-title>HIV-1 dynamics in vivo: Virion clearance rate, infected cell life-span, and viral generation time</article-title>. <source>Science</source>. <volume>271</volume>:<fpage>1582</fpage>&#x02013;<lpage>1586</lpage>. <pub-id pub-id-type="doi">10.1126/science.271.5255.1582</pub-id><pub-id pub-id-type="pmid">8599114</pub-id>
</mixed-citation></ref><ref id="bib55"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Pinzone</surname>, <given-names>M.R.</given-names></string-name>, <string-name><given-names>D.J.</given-names><surname>VanBelzen</surname></string-name>, <string-name><given-names>S.</given-names><surname>Weissman</surname></string-name>, <string-name><given-names>M.P.</given-names><surname>Bertuccio</surname></string-name>, <string-name><given-names>L.</given-names><surname>Cannon</surname></string-name>, <string-name><given-names>E.</given-names><surname>Venanzi-Rullo</surname></string-name>, <string-name><given-names>S.</given-names><surname>Migueles</surname></string-name>, <string-name><given-names>R.B.</given-names><surname>Jones</surname></string-name>, <string-name><given-names>T.</given-names><surname>Mota</surname></string-name>, <string-name><given-names>S.B.</given-names><surname>Joseph</surname></string-name>, <etal/></person-group>. <year>2019</year>. <article-title>Longitudinal HIV sequencing reveals reservoir expression leading to decay which is obscured by clonal expansion</article-title>. <source>Nat. Commun.</source><volume>10</volume>:<fpage>728</fpage>. <pub-id pub-id-type="doi">10.1038/s41467-019-08431-7</pub-id><pub-id pub-id-type="pmid">30760706</pub-id>
</mixed-citation></ref><ref id="bib56"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Raj</surname>, <given-names>A.</given-names></string-name>, and <string-name><given-names>A.</given-names><surname>van Oudenaarden</surname></string-name></person-group>. <year>2008</year>. <article-title>Nature, nurture, or chance: Stochastic gene expression and its consequences</article-title>. <source>Cell</source>. <volume>135</volume>:<fpage>216</fpage>&#x02013;<lpage>226</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2008.09.050</pub-id><pub-id pub-id-type="pmid">18957198</pub-id>
</mixed-citation></ref><ref id="bib57"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Salazar-Gonzalez</surname>, <given-names>J.F.</given-names></string-name>, <string-name><given-names>E.</given-names><surname>Bailes</surname></string-name>, <string-name><given-names>K.T.</given-names><surname>Pham</surname></string-name>, <string-name><given-names>M.G.</given-names><surname>Salazar</surname></string-name>, <string-name><given-names>M.B.</given-names><surname>Guffey</surname></string-name>, <string-name><given-names>B.F.</given-names><surname>Keele</surname></string-name>, <string-name><given-names>C.A.</given-names><surname>Derdeyn</surname></string-name>, <string-name><given-names>P.</given-names><surname>Farmer</surname></string-name>, <string-name><given-names>E.</given-names><surname>Hunter</surname></string-name>, <string-name><given-names>S.</given-names><surname>Allen</surname></string-name>, <etal/></person-group>. <year>2008</year>. <article-title>Deciphering human immunodeficiency virus type 1 transmission and early envelope diversification by single-genome amplification and sequencing</article-title>. <source>J. Virol.</source><volume>82</volume>:<fpage>3952</fpage>&#x02013;<lpage>3970</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.02660-07</pub-id><pub-id pub-id-type="pmid">18256145</pub-id>
</mixed-citation></ref><ref id="bib58"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Saleh</surname>, <given-names>S.</given-names></string-name>, <string-name><given-names>F.</given-names><surname>Wightman</surname></string-name>, <string-name><given-names>S.</given-names><surname>Ramanayake</surname></string-name>, <string-name><given-names>M.</given-names><surname>Alexander</surname></string-name>, <string-name><given-names>N.</given-names><surname>Kumar</surname></string-name>, <string-name><given-names>G.</given-names><surname>Khoury</surname></string-name>, <string-name><given-names>C.</given-names><surname>Pereira</surname></string-name>, <string-name><given-names>D.</given-names><surname>Purcell</surname></string-name>, <string-name><given-names>P.U.</given-names><surname>Cameron</surname></string-name>, and <string-name><given-names>S.R.</given-names><surname>Lewin</surname></string-name></person-group>. <year>2011</year>. <article-title>Expression and reactivation of HIV in a chemokine induced model of HIV latency in primary resting CD4+ T cells</article-title>. <source>Retrovirology</source>. <volume>8</volume>:<fpage>80</fpage>. <pub-id pub-id-type="doi">10.1186/1742-4690-8-80</pub-id><pub-id pub-id-type="pmid">21992606</pub-id>
</mixed-citation></ref><ref id="bib59"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>De Scheerder</surname>, <given-names>M.A.</given-names></string-name>, <string-name><given-names>B.</given-names><surname>Vrancken</surname></string-name>, <string-name><given-names>S.</given-names><surname>Dellicour</surname></string-name>, <string-name><given-names>T.</given-names><surname>Schlub</surname></string-name>, <string-name><given-names>E.</given-names><surname>Lee</surname></string-name>, <string-name><given-names>W.</given-names><surname>Shao</surname></string-name>, <string-name><given-names>S.</given-names><surname>Rutsaert</surname></string-name>, <string-name><given-names>C.</given-names><surname>Verhofstede</surname></string-name>, <string-name><given-names>T.</given-names><surname>Kerre</surname></string-name>, <string-name><given-names>T.</given-names><surname>Malfait</surname></string-name>, <etal/></person-group>. <year>2019</year>. <article-title>HIV rebound is predominantly fueled by genetically identical viral expansions from diverse reservoirs</article-title>. <source>Cell Host Microbe</source>. <volume>26</volume>:<fpage>347</fpage>&#x02013;<lpage>358.e7</lpage>. <pub-id pub-id-type="doi">10.1016/j.chom.2019.08.003</pub-id><pub-id pub-id-type="pmid">31471273</pub-id>
</mixed-citation></ref><ref id="bib60"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Schr&#x000f6;der</surname>, <given-names>A.R.W.</given-names></string-name>, <string-name><given-names>P.</given-names><surname>Shinn</surname></string-name>, <string-name><given-names>H.</given-names><surname>Chen</surname></string-name>, <string-name><given-names>C.</given-names><surname>Berry</surname></string-name>, <string-name><given-names>J.R.</given-names><surname>Ecker</surname></string-name>, and <string-name><given-names>F.</given-names><surname>Bushman</surname></string-name></person-group>. <year>2002</year>. <article-title>HIV-1 integration in the human genome favors active genes and local hotspots</article-title>. <source>Cell</source>. <volume>110</volume>:<fpage>521</fpage>&#x02013;<lpage>529</lpage>. <pub-id pub-id-type="doi">10.1016/S0092-8674(02)00864-4</pub-id><pub-id pub-id-type="pmid">12202041</pub-id>
</mixed-citation></ref><ref id="bib61"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Sherrill-Mix</surname>, <given-names>S.</given-names></string-name>, <string-name><given-names>M.K.</given-names><surname>Lewinski</surname></string-name>, <string-name><given-names>M.</given-names><surname>Famiglietti</surname></string-name>, <string-name><given-names>A.</given-names><surname>Bosque</surname></string-name>, <string-name><given-names>N.</given-names><surname>Malani</surname></string-name>, <string-name><given-names>K.E.</given-names><surname>Ocwieja</surname></string-name>, <string-name><given-names>C.C.</given-names><surname>Berry</surname></string-name>, <string-name><given-names>D.</given-names><surname>Looney</surname></string-name>, <string-name><given-names>L.</given-names><surname>Shan</surname></string-name>, <string-name><given-names>L.M.</given-names><surname>Agosto</surname></string-name>, <etal/></person-group>. <year>2013</year>. <article-title>HIV latency and integration site placement in five cell-based models</article-title>. <source>Retrovirology</source>. <volume>10</volume>:<fpage>90</fpage>. <pub-id pub-id-type="doi">10.1186/1742-4690-10-90</pub-id><pub-id pub-id-type="pmid">23953889</pub-id>
</mixed-citation></ref><ref id="bib62"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Siliciano</surname>, <given-names>J.D.</given-names></string-name>, <string-name><given-names>J.</given-names><surname>Kajdas</surname></string-name>, <string-name><given-names>D.</given-names><surname>Finzi</surname></string-name>, <string-name><given-names>T.C.</given-names><surname>Quinn</surname></string-name>, <string-name><given-names>K.</given-names><surname>Chadwick</surname></string-name>, <string-name><given-names>J.B.</given-names><surname>Margolick</surname></string-name>, <string-name><given-names>C.</given-names><surname>Kovacs</surname></string-name>, <string-name><given-names>S.J.</given-names><surname>Gange</surname></string-name>, and <string-name><given-names>R.F.</given-names><surname>Siliciano</surname></string-name></person-group>. <year>2003</year>. <article-title>Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4<sup>+</sup> T cells</article-title>. <source>Nat. Med.</source><volume>9</volume>:<fpage>727</fpage>&#x02013;<lpage>728</lpage>. <pub-id pub-id-type="doi">10.1038/nm880</pub-id><pub-id pub-id-type="pmid">12754504</pub-id>
</mixed-citation></ref><ref id="bib63"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Siliciano</surname>, <given-names>J.D.</given-names></string-name>, and <string-name><given-names>R.F.</given-names><surname>Siliciano</surname></string-name></person-group>. <year>2022</year>. <article-title>In vivo dynamics of the latent reservoir for HIV-1: New insights and implications for cure</article-title>. <source>Annu. Rev. Pathol.</source><volume>17</volume>:<fpage>271</fpage>&#x02013;<lpage>294</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-pathol-050520-112001</pub-id><pub-id pub-id-type="pmid">34736342</pub-id>
</mixed-citation></ref><ref id="bib64"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Simonetti</surname>, <given-names>F.R.</given-names></string-name>, <string-name><given-names>M.D.</given-names><surname>Sobolewski</surname></string-name>, <string-name><given-names>E.</given-names><surname>Fyne</surname></string-name>, <string-name><given-names>W.</given-names><surname>Shao</surname></string-name>, <string-name><given-names>J.</given-names><surname>Spindler</surname></string-name>, <string-name><given-names>J.</given-names><surname>Hattori</surname></string-name>, <string-name><given-names>E.M.</given-names><surname>Anderson</surname></string-name>, <string-name><given-names>S.A.</given-names><surname>Watters</surname></string-name>, <string-name><given-names>S.</given-names><surname>Hill</surname></string-name>, <string-name><given-names>X.</given-names><surname>Wu</surname></string-name>, <etal/></person-group>. <year>2016</year>. <article-title>Clonally expanded CD4<sup>+</sup> T cells can produce infectious HIV-1 in vivo</article-title>. <source>Proc. Natl. Acad. Sci. USA</source>. <volume>113</volume>:<fpage>1883</fpage>&#x02013;<lpage>1888</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1522675113</pub-id><pub-id pub-id-type="pmid">26858442</pub-id>
</mixed-citation></ref><ref id="bib65"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Simonetti</surname>, <given-names>F.R.</given-names></string-name>, <string-name><given-names>H.</given-names><surname>Zhang</surname></string-name>, <string-name><given-names>G.P.</given-names><surname>Soroosh</surname></string-name>, <string-name><given-names>J.</given-names><surname>Duan</surname></string-name>, <string-name><given-names>K.</given-names><surname>Rhodehouse</surname></string-name>, <string-name><given-names>A.L.</given-names><surname>Hill</surname></string-name>, <string-name><given-names>S.A.</given-names><surname>Beg</surname></string-name>, <string-name><given-names>K.</given-names><surname>McCormick</surname></string-name>, <string-name><given-names>H.E.</given-names><surname>Raymond</surname></string-name>, <string-name><given-names>C.L.</given-names><surname>Nobles</surname></string-name>, <etal/></person-group>. <year>2021</year>. <article-title>Antigen-driven clonal selection shapes the persistence of HIV-1&#x02013;infected CD4<sup>+</sup> T cells in vivo</article-title>. <source>J. Clin. Invest.</source><volume>131</volume>:<elocation-id>e145254</elocation-id>. <pub-id pub-id-type="doi">10.1172/JCI145254</pub-id><pub-id pub-id-type="pmid">33301425</pub-id>
</mixed-citation></ref><ref id="bib66"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Skupsky</surname>
<given-names>R.</given-names>
</string-name>, <string-name><given-names>J.C.</given-names><surname>Burnett</surname></string-name>, <string-name><given-names>J.E.</given-names><surname>Foley</surname></string-name>, <string-name><given-names>D.V.</given-names><surname>Schaffer</surname></string-name>, and <string-name><given-names>A.P.</given-names><surname>Arkin</surname></string-name></person-group>. <year>2010</year>. <article-title>HIV promoter integration site primarily modulates transcriptional burst size rather than frequency</article-title>. <source>PLoS Comput. Biol.</source><volume>6</volume>:<elocation-id>e1000952</elocation-id>. <pub-id pub-id-type="doi">10.1371/journal.pcbi.1000952</pub-id><pub-id pub-id-type="pmid">20941390</pub-id>
</mixed-citation></ref><ref id="bib67"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Sun</surname>, <given-names>W.</given-names></string-name>, <string-name><given-names>C.</given-names><surname>Gao</surname></string-name>, <string-name><given-names>C.A.</given-names><surname>Hartana</surname></string-name>, <string-name><given-names>M.R.</given-names><surname>Osborn</surname></string-name>, <string-name><given-names>K.B.</given-names><surname>Einkauf</surname></string-name>, <string-name><given-names>X.</given-names><surname>Lian</surname></string-name>, <string-name><given-names>B.</given-names><surname>Bone</surname></string-name>, <string-name><given-names>N.</given-names><surname>Bonheur</surname></string-name>, <string-name><given-names>T.W.</given-names><surname>Chun</surname></string-name>, <string-name><given-names>E.S.</given-names><surname>Rosenberg</surname></string-name>, <etal/></person-group>. <year>2023</year>. <article-title>Phenotypic signatures of immune selection in HIV-1 reservoir cells</article-title>. <source>Nature</source>. <volume>614</volume>:<fpage>309</fpage>&#x02013;<lpage>317</lpage>. <pub-id pub-id-type="doi">10.1038/s41586-022-05538-8</pub-id><pub-id pub-id-type="pmid">36599977</pub-id>
</mixed-citation></ref><ref id="bib68"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Wei</surname>, <given-names>X.</given-names></string-name>, <string-name><given-names>S.K.</given-names><surname>Ghosh</surname></string-name>, <string-name><given-names>M.E.</given-names><surname>Taylor</surname></string-name>, <string-name><given-names>V.A.</given-names><surname>Johnson</surname></string-name>, <string-name><given-names>E.A.</given-names><surname>Emini</surname></string-name>, <string-name><given-names>P.</given-names><surname>Deutsch</surname></string-name>, <string-name><given-names>J.D.</given-names><surname>Lifson</surname></string-name>, <string-name><given-names>S.</given-names><surname>Bonhoeffer</surname></string-name>, <string-name><given-names>M.A.</given-names><surname>Nowak</surname></string-name>, <string-name><given-names>B.H.</given-names><surname>Hahn</surname></string-name>, <etal/></person-group>. <year>1995</year>. <article-title>Viral dynamics in human immunodeficiency virus type 1 infection</article-title>. <source>Nature</source>. <volume>373</volume>:<fpage>117</fpage>&#x02013;<lpage>122</lpage>. <pub-id pub-id-type="doi">10.1038/373117a0</pub-id><pub-id pub-id-type="pmid">7529365</pub-id>
</mixed-citation></ref><ref id="bib69"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Weymar</surname>, <given-names>G.H.J.</given-names></string-name>, <string-name><given-names>Y.</given-names><surname>Bar-On</surname></string-name>, <string-name><given-names>T.Y.</given-names><surname>Oliveira</surname></string-name>, <string-name><given-names>C.</given-names><surname>Gaebler</surname></string-name>, <string-name><given-names>V.</given-names><surname>Ramos</surname></string-name>, <string-name><given-names>H.</given-names><surname>Hartweger</surname></string-name>, <string-name><given-names>G.</given-names><surname>Breton</surname></string-name>, <string-name><given-names>M.</given-names><surname>Caskey</surname></string-name>, <string-name><given-names>L.B.</given-names><surname>Cohn</surname></string-name>, <string-name><given-names>M.</given-names><surname>Jankovic</surname></string-name>, and <string-name><given-names>M.C.</given-names><surname>Nussenzweig</surname></string-name></person-group>. <year>2022</year>. <article-title>Distinct gene expression by expanded clones of quiescent memory CD4<sup>+</sup> T cells harboring intact latent HIV-1 proviruses</article-title>. <source>Cell Rep.</source><volume>40</volume>:<fpage>111311</fpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2022.111311</pub-id><pub-id pub-id-type="pmid">36070690</pub-id>
</mixed-citation></ref><ref id="bib70"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Wong</surname>, <given-names>J.K.</given-names></string-name>, <string-name><given-names>M.</given-names><surname>Hezareh</surname></string-name>, <string-name><given-names>H.F.</given-names><surname>G&#x000fc;nthard</surname></string-name>, <string-name><given-names>D.V.</given-names><surname>Havlir</surname></string-name>, <string-name><given-names>C.C.</given-names><surname>Ignacio</surname></string-name>, <string-name><given-names>C.A.</given-names><surname>Spina</surname></string-name>, and <string-name><given-names>D.D.</given-names><surname>Richman</surname></string-name></person-group>. <year>1997</year>. <article-title>Recovery of replication-competent HIV despite prolonged suppression of plasma viremia</article-title>. <source>Science</source>. <volume>278</volume>:<fpage>1291</fpage>&#x02013;<lpage>1295</lpage>. <pub-id pub-id-type="doi">10.1126/science.278.5341.1291</pub-id><pub-id pub-id-type="pmid">9360926</pub-id>
</mixed-citation></ref><ref id="bib71"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Wong</surname>, <given-names>M.</given-names></string-name>, <string-name><given-names>Y.</given-names><surname>Wei</surname></string-name>, and <string-name><given-names>Y.-C.</given-names><surname>Ho</surname></string-name></person-group>. <year>2023</year>. <article-title>Single-cell multiomic understanding of HIV-1 reservoir at epigenetic, transcriptional, and protein levels</article-title>. <source>Curr. Opin. HIV AIDS</source>. <volume>18</volume>:<fpage>246</fpage>&#x02013;<lpage>256</lpage>. <pub-id pub-id-type="doi">10.1097/COH.0000000000000809</pub-id><pub-id pub-id-type="pmid">37535039</pub-id>
</mixed-citation></ref><ref id="bib72"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Wu</surname>, <given-names>V.H.</given-names></string-name>, <string-name><given-names>J.M.L.</given-names><surname>Nordin</surname></string-name>, <string-name><given-names>S.</given-names><surname>Nguyen</surname></string-name>, <string-name><given-names>J.</given-names><surname>Joy</surname></string-name>, <string-name><given-names>F.</given-names><surname>Mampe</surname></string-name>, <string-name><given-names>P.M.</given-names><surname>Del Rio Estrada</surname></string-name>, <string-name><given-names>F.</given-names><surname>Torres-Ruiz</surname></string-name>, <string-name><given-names>M.</given-names><surname>Gonz&#x000e1;lez-Navarro</surname></string-name>, <string-name><given-names>Y.A.</given-names><surname>Luna-Villalobos</surname></string-name>, <string-name><given-names>S.</given-names><surname>&#x000c1;vila-R&#x000ed;os</surname></string-name>, <etal/></person-group>. <year>2023</year>. <article-title>Profound phenotypic and epigenetic heterogeneity of the HIV-1-infected CD4<sup>+</sup> T cell reservoir</article-title>. <source>Nat. Immunol.</source><volume>24</volume>:<fpage>359</fpage>&#x02013;<lpage>370</lpage>. <pub-id pub-id-type="doi">10.1038/s41590-022-01371-3</pub-id><pub-id pub-id-type="pmid">36536105</pub-id>
</mixed-citation></ref><ref id="bib73"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Yeh</surname>, <given-names>Y.J.</given-names></string-name>, <string-name><given-names>K.M.</given-names><surname>Jenike</surname></string-name>, <string-name><given-names>R.M.</given-names><surname>Calvi</surname></string-name>, <string-name><given-names>J.</given-names><surname>Chiarella</surname></string-name>, <string-name><given-names>R.</given-names><surname>Hoh</surname></string-name>, <string-name><given-names>S.G.</given-names><surname>Deeks</surname></string-name>, and <string-name><given-names>Y.-C.</given-names><surname>Ho</surname></string-name></person-group>. <year>2020</year>. <article-title>Filgotinib suppresses HIV-1-driven gene transcription by inhibiting HIV-1 splicing and T cell activation</article-title>. <source>J. Clin. Invest.</source><volume>130</volume>:<fpage>4969</fpage>&#x02013;<lpage>4984</lpage>. <pub-id pub-id-type="doi">10.1172/JCI137371</pub-id><pub-id pub-id-type="pmid">32573496</pub-id>
</mixed-citation></ref></ref-list></back></article>